var title_f7_60_8128="Cat scratch disease typical papular lesion";
var content_f7_60_8128=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F78770&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F78770&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Typical papular lesion on the finger of a child with cat scratch disease",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 371px; height: 278px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Sheldon L Kaplan, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f7_60_8128=[""].join("\n");
var outline_f7_60_8128=null;
var title_f7_60_8129="Calculator: Maintenance fluid calculation for children";
var content_f7_60_8129=[" <div id=\"topicText\">",
"  <div id=\"mc3k\">",
"   <form action=\"\" id=\"MaintenanceFluidChildren_form\" name=\"MaintenanceFluidChildren_form\" onkeydown=\"clrResults();\" onkeyup=\"MaintenanceFluidChildren_fx();\" onsubmit=\"return false;\">",
"    <table cellpadding=\"4\" cellspacing=\"0\" summary=\"MedCalc 3000 Table\" width=\"100%\">",
"     <tr>",
"      <td bgcolor=\"#eeeeee\" width=\"1%\">",
"       <br/>",
"      </td>",
"      <td align=\"left\" bgcolor=\"#eeeeee\">",
"       <span class=\"medCalcFontTitleBox\">",
"        Calculator: Maintenance fluid calculation for children",
"       </span>",
"      </td>",
"     </tr>",
"    </table>",
"    <br/>",
"    &nbsp;",
"    <br/>",
"    <center>",
"     <div id=\"calc_equation\">",
"      <table cellpadding=\"10\" cellspacing=\"0\" summary=\"MedCalc 3000 Table\">",
"       <tr>",
"        <td align=\"left\" bgcolor=\"#6c9a9c\">",
"         <span class=\"medCalcFontFormuli\">",
"          FluidRate = DailyVol / 24",
"         </span>",
"        </td>",
"       </tr>",
"      </table>",
"      <br/>",
"      &nbsp;",
"      <br/>",
"     </div>",
"    </center>",
"    <div id=\"calc_main\">",
"     <center>",
"      <table cellpadding=\"6\" cellspacing=\"0\" summary=\"MedCalc 3000 Table\" width=\"95%\">",
"       <tr>",
"        <td align=\"right\" width=\"50%\">",
"         <center>",
"          <span class=\"medCalcFontIO\">",
"           Input:",
"          </span>",
"          <br/>",
"          &nbsp;",
"          <br/>",
"          <table cellpadding=\"3\" cellspacing=\"0\" summary=\"MedCalc 3000 Table\">",
"           <tr>",
"            <td align=\"right\" width=\"42%\">",
"             <span class=\"medCalcFontOneBold\">",
"              Weight",
"             </span>",
"            </td>",
"            <td align=\"left\" nowrap=\"nowrap\" valign=\"top\" width=\"5%\">",
"             &nbsp;",
"             <input name=\"Weight_param\" onblur=\"MaintenanceFluidChildren_fx(); minMaxCheck();\" onchange=\"MaintenanceFluidChildren_fx();\" size=\"6\" type=\"text\" value=\"\"/>",
"            </td>",
"            <td align=\"left\" valign=\"top\" width=\"115\">",
"             <select class=\"medCalcFontSelect\" name=\"Weight_unit\" onchange=\"MaintenanceFluidChildren_fx();\" style=\"width:105px;\">",
"              <option selected=\"selected\" value=\"1|0|kg\">",
"               kg",
"              </option>",
"              <option value=\"0.45359237|0|lb\">",
"               lb",
"              </option>",
"             </select>",
"            </td>",
"           </tr>",
"          </table>",
"         </center>",
"        </td>",
"        <td align=\"left\" bgcolor=\"#eeeeee\">",
"         <center>",
"          <span class=\"medCalcFontIO\">",
"           Results:",
"          </span>",
"          <br/>",
"          &nbsp;",
"          <br/>",
"          <table bgcolor=\"#eeeeee\" cellspacing=\"4\" summary=\"MedCalc 3000 Table\">",
"           <tr>",
"            <td align=\"right\">",
"             <span class=\"medCalcFontOneBold\">",
"              Daily Volume (mL)",
"             </span>",
"            </td>",
"            <td nowrap=\"nowrap\" valign=\"top\">",
"             &nbsp;",
"             <input maxlength=\"6\" name=\"daily_vol_result\" onfocus=\"blur();\" size=\"6\" type=\"text\"/>",
"            </td>",
"           </tr>",
"           <tr>",
"            <td align=\"right\">",
"             <span class=\"medCalcFontOneBold\">",
"              Fluid Rate",
"             </span>",
"            </td>",
"            <td nowrap=\"nowrap\" valign=\"top\">",
"             &nbsp;",
"             <input name=\"Fluid_Rate_param\" onfocus=\"blur();\" size=\"6\" type=\"text\"/>",
"            </td>",
"            <td valign=\"top\">",
"             <span class=\"medCalcFontOne\">",
"              <select class=\"medCalcFontSelect\" name=\"Fluid_Rate_unit\" onchange=\"MaintenanceFluidChildren_fx();\" style=\"width:105px;\">",
"               <option value=\"999.99999982|0|L/hr\">",
"                L/hr",
"               </option>",
"               <option selected=\"selected\" value=\"1|0|mL/hr\">",
"                mL/hr",
"               </option>",
"               <option value=\"59.999999988|0|mL/min\">",
"                mL/min",
"               </option>",
"              </select>",
"             </span>",
"            </td>",
"           </tr>",
"           <tr>",
"            <td colspan=\"3\">",
"             &nbsp;",
"             <br/>",
"            </td>",
"           </tr>",
"          </table>",
"         </center>",
"         <br/>",
"         &nbsp;",
"         <br/>",
"         <center>",
"          <span class=\"medCalcFontOne\">",
"           <input name=\"reset\" type=\"reset\" value=\"Reset form\"/>",
"          </span>",
"         </center>",
"        </td>",
"       </tr>",
"      </table>",
"     </center>",
"    </div>",
"    <br/>",
"    &nbsp;",
"    <br/>",
"    <div id=\"calc_hints\">",
"     <span class=\"medCalcFontOne\">",
"     </span>",
"    </div>",
"    <div id=\"calc_notes\">",
"     <span class=\"medCalcFontOneBold\">",
"      Notes",
"     </span>",
"     <ul class=\"medCalcFontOne\">",
"      <li>",
"       For infants 3.5 to 10 kg the daily fluid requirement is 100 mL/kg.",
"      </li>",
"      <li>",
"       For children 11-20 kg the daily fluid requirement is 1000 mL + 50 mL/kg for every kg over 10.",
"      </li>",
"      <li>",
"       For children &gt;20 kg the daily fluid requirement is 1500 mL + 20 mL/kg for every kg over 20,",
"       <font color=\"#aa0000\">",
"        <b>",
"         up to a maximum of 2400 mL daily.",
"        </b>",
"       </font>",
"      </li>",
"      <li>",
"       Please note that this calculation does not apply to newborn infants (ie, from 0 to 28 days after full term delivery).",
"      </li>",
"     </ul>",
"    </div>",
"    <br/>",
"    &nbsp;",
"    <br/>",
"    <div id=\"calc_refs\">",
"     <span class=\"medCalcFontRef\">",
"      <b>",
"       References",
"      </b>",
"     </span>",
"     <ol>",
"      <li>",
"       <span class=\"medCalcFontRef\">",
"        Holliday MA, Segar WE. The maintenance need for water in parenteral fluid therapy.",
"        <i>",
"         Pediatrics",
"        </i>",
"        . Vol. 19, 1957 823-832.",
"       </span>",
"      </li>",
"     </ol>",
"    </div>",
"   </form>",
"  </div>",
" </div>",
" <div id=\"topicAgreement\">",
"  Use of UpToDate is subject to the",
"  <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"   Subscription and License Agreement",
"  </a>",
"  .",
" </div>",
" <div id=\"printDisclaimer\">",
"  Information on this page may not appear correctly if printed.",
" </div>",
" <div id=\"disclaimerCalculator\">",
"  <div class=\"medCalcFontTwo\">",
"   <p class=\"header\">",
"    Legal Notices and Disclaimer",
"   </p>",
"   <p>",
"    All information contained in and produced by the MedCalc 3000 system is provided",
"			for educational purposes only. This information should not be used for the diagnosis or treatment",
"			of any health problem or disease.",
"    <b>",
"     THIS INFORMATION IS NOT INTENDED TO REPLACE CLINICAL JUDGMENT OR",
"			GUIDE INDIVIDUAL PATIENT CARE IN ANY MANNER.",
"    </b>",
"    <a class=\"medCalcDisclaimerLink\" href=\"./med-calc-disclaimer\">",
"     Click here for",
"				full notice and disclaimer.",
"    </a>",
"   </p>",
"   <p class=\"copy\">",
"    MedCalc 3000 is Copyright &copy; 1998-2013 Foundation Internet Services",
"   </p>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f7_60_8129=[" ",
"",
"",
"function log(i){",
"return Math.log(i) * Math.LOG10E;   ",
"}",
"",
"function ln(i){",
"return Math.log(i);",
"}",
"",
"function sq(i){",
"return i * i;",
"}",
"",
"function sqr(i){",
"return Math.sqrt(i);",
"}",
"",
"",
"function power(x,y){",
"return Math.pow(x,y);",
"}",
"",
"function eTo(x){",
"return Math.exp(x);",
"}",
"",
"",
"function fixDP(r, dps) {",
"if (isNaN(r)) return \"NaN\";",
"var msign = '';",
"if (r < 0) msign = '-';",
"x = Math.abs(r);",
"if (x > Math.pow(10, 21)) return msign + x.toString();",
"var m = Math.round(x * Math.pow(10, dps)).toString();",
"if (dps == 0) return msign + m;",
"while (m.length <= dps) m = \"0\" + m;",
"return msign + m.substring(0, m.length - dps) + \".\" + m.substring(m.length - dps);",
"}",
"",
"function alertNaN(thisparam){",
"alert(thisparam + ' is improperly formatted. You may only input the digits 0-9 and a decimal point.');  ",
"doCalc = false; ",
"clrResults();",
"}",
"",
"var currenttimeout;",
"",
"",
"var calctxt = ''; ",
"var xmltxt = ''; ",
"var htmtxt = ''; ",
"",
"",
"",
"function MaintenanceFluidChildren_fx() {",
"",
"currenttimeout = self.setTimeout('minMaxCheck();', 2000);",
"",
"with(document.MaintenanceFluidChildren_form){",
"",
"",
"doCalc = true;",
"param_value = parseFloat(Weight_param.value);",
"if (isNaN(param_value)){param_value = \"\"; doCalc = false;}",
"unit_parts = Weight_unit.options[Weight_unit.selectedIndex].value.split('|');",
"Weight = param_value * parseFloat(unit_parts[0]) + parseFloat(unit_parts[1]);",
"dp = 0;",
"if(Weight < 10) Daily_Vol = 100 * Weight;",
"if((Weight >= 10) && (Weight < 20 )) Daily_Vol = 1000 + (50 * (Weight - 10));",
"if(Weight >= 20) Daily_Vol = 1500 + (20 * (Weight - 20));",
"if (Daily_Vol > 2400) Daily_Vol = 2400;",
"daily_vol_result.value = Math.round(10 * Daily_Vol) / 10;",
"Fluid_Rate =  Daily_Vol / 24;",
"",
"unit_parts = Fluid_Rate_unit.options[Fluid_Rate_unit.selectedIndex].value.split('|');",
"if (doCalc) Fluid_Rate_param.value = fixDP((Fluid_Rate - parseFloat(unit_parts[1])) / parseFloat(unit_parts[0]), dp);",
"",
"",
"",
"",
"",
"}",
"",
"}",
"",
"function minMaxCheck(){",
"",
"if (currenttimeout) self.clearTimeout(currenttimeout);",
"",
"with(document.MaintenanceFluidChildren_form){",
"",
"if (Weight_param.value && isNaN(Weight_param.value)){ Weight_param.value = ''; alertNaN('Weight'); }",
"if (Weight_param.value && Weight < 3.499) {",
"Weight = 0;",
"Weight_param.value = \"\";",
"clrResults();",
"doCalc = false;",
"alert(\"The minimum value for Weight is 3.499 kg.\\nIf you are specifying a value with a different unit,\\nchange the unit selector first.\");",
"}",
"if (Weight_param.value && Weight > 200) {",
"Weight_param.value = \"\";",
"clrResults();",
"Weight = 0;",
"doCalc = false;",
"alert(\"The maximum value for Weight is 200 kg.\\nIf you are specifying a value with a different unit,\\nchange the unit selector first.\");",
"}",
"",
"",
"}",
"",
"}",
"",
"",
"function clrResults(){",
"",
"if (currenttimeout) self.clearTimeout(currenttimeout);",
"",
"with(document.MaintenanceFluidChildren_form){",
"",
"daily_vol_result.value = '';",
"Fluid_Rate_param.value = '';",
"",
"",
"}",
"",
"}",
"",
"",
"",
"",
"",
"",
"",
"",
"",
"",
"",
""].join("\n");
var outline_f7_60_8129=null;
var title_f7_60_8130="Patient information: Gastroparesis (delayed gastric emptying) (The Basics)";
var content_f7_60_8130=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div>",
"   &nbsp;",
"  </div>",
"  <div id=\"basicsTopicMinWidth\">",
"   <div id=\"basicsTopicRight\">",
"    <div id=\"placeholder\">",
"     <div id=\"basics-graphics\">",
"      <span class=\"basics-box-top\">",
"      </span>",
"      <h4>",
"       <img src=\"file://www.uptodate.com/images/basics-graphics-title.png\"/>",
"       <span class=\"openRelatedGraphics\" id=\"PI/16403\" rel=\"graphic_box\">",
"        <a href=\"#\" title=\"View All Related Graphics\">",
"         View All",
"        </a>",
"       </span>",
"      </h4>",
"      <ul>",
"       <li>",
"        <a class=\"graphic graphic_figure\" href=\"UTD.htm?28/27/29107\">",
"         Digestive system",
"        </a>",
"       </li>",
"      </ul>",
"      <a href=\"#\" id=\"basics-seeall\">",
"       See All Graphics",
"      </a>",
"     </div>",
"     <script type=\"text/javascript\">",
"      if ($(\"#basics-graphics li\").length &lt;= 4) {",
"				$(\"#basics-seeall\").remove();",
"			} else {",
"				$(\"#basics-graphics li:gt(3)\").addClass(\"hidden\");",
"				$(\"#basics-seeall\").click(function(){",
"					$(\"#basics-graphics li.hidden\").removeClass(\"hidden\");",
"					$(this).remove();",
"					return false;",
"				});",
"			}",
"     </script>",
"     <div class=\"ieSpacer\">",
"     </div>",
"     <div id=\"basics-more\">",
"      <h4>",
"       <img src=\"file://www.uptodate.com/images/basics-more-title.png\"/>",
"      </h4>",
"      <dl>",
"       <dt class=\"basics\">",
"        The Basics",
"       </dt>",
"       <dd>",
"        <a href=\"UTD.htm?27/57/28562\">",
"         Patient information: Nausea and vomiting in adults (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?32/41/33426\">",
"         Patient information: Upper endoscopy (The Basics)",
"        </a>",
"       </dd>",
"       <dt class=\"beyondthebasics\">",
"        Beyond the Basics",
"       </dt>",
"       <dd>",
"        <a href=\"UTD.htm?21/0/21506\">",
"         Patient information: Upper endoscopy (Beyond the Basics)",
"        </a>",
"       </dd>",
"      </dl>",
"      <div id=\"tooltipper\">",
"      </div>",
"     </div>",
"    </div>",
"   </div>",
"   <div id=\"basicsTopicLeft\">",
"    <div id=\"topicTitle\">",
"     Patient information: Gastroparesis (delayed gastric emptying) (The Basics)",
"    </div>",
"    <span class=\"view\">",
"     View in",
"     <a class=\"lang\" href=\"./es-419/gastroparesis-delayed-gastric-emptying-the-basics?source=topic_page\">",
"      Spanish",
"     </a>",
"    </span>",
"    <a class=\"contributor contributor_credentials\" href=\"./authors-and-editors/patient-information\">",
"     Written by the doctors and editors at UpToDate",
"    </a>",
"    <div id=\"topicText\">",
"     <p class=\"headingAnchor\" id=\"H2420075\">",
"      <span class=\"h1\">",
"       What is gastroparesis?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Gastroparesis is a condition that causes nausea and vomiting. It can also make you feel full too soon after you start eating. It happens because the stomach takes too long to empty and does not move food along through your body fast enough (",
"      <a class=\"graphic graphic_figure graphicRef66110 \" href=\"UTD.htm?28/27/29107\">",
"       figure 1",
"      </a>",
"      ). Gastroparesis is also called &ldquo;delayed gastric emptying.&rdquo; (&ldquo;Gastric&rdquo; means &ldquo;having to do with the stomach.&rdquo;)",
"     </p>",
"     <p>",
"      Gastroparesis is a common problem among people with diabetes. It also can happen to people who have had food poisoning (gastroenteritis). But it can also happen to people who have not been sick and who do not have diabetes.",
"     </p>",
"     <p>",
"      When gastroparesis starts after someone has had food poisoning, it often gets better in a few days to weeks. Sometimes it lasts longer or never goes away. In people with diabetes, it usually does not go away, but there are things that can make it better.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H2420082\">",
"      <span class=\"h1\">",
"       What are the symptoms of gastroparesis?",
"      </span>",
"      &nbsp;&mdash;&nbsp;The symptoms can include:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        Nausea with or without vomiting",
"       </li>",
"       <li>",
"        Belly pain",
"       </li>",
"       <li>",
"        Feeling full too soon after you start eating",
"       </li>",
"       <li>",
"        Bloating (feeling as though your stomach is full of air)",
"       </li>",
"       <li>",
"        Weight loss",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H2420089\">",
"      <span class=\"h1\">",
"       Is there a test for gastroparesis?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Yes. If your doctor or nurse suspects you have gastroparesis, he or she might do 1 or more of these tests:",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        <strong>",
"         Endoscopy",
"        </strong>",
"        &ndash; To prepare for an endoscopy, you eat normally the day before the test but eat nothing the day of the test. For the test, a doctor or nurse puts a thin tube down your throat and into your stomach. The tube (called an endoscope) has a light and a tiny camera on the end, so it allows the doctor or nurse to see inside your stomach. If he or she still finds food in your stomach even though it has been more than 8 hours since you ate, that is a sign that you might have gastroparesis.",
"       </li>",
"       <li>",
"        <a class=\"drug drug_patient\" href=\"UTD.htm?18/37/19028?source=see_link\">",
"         Barium",
"        </a>",
"        <strong>",
"         swallow",
"        </strong>",
"        &ndash; For this test you eat a special meal that shows up on X-ray. Then you have X-rays taken to see how long it takes for the food to leave your stomach.",
"       </li>",
"       <li>",
"        <strong>",
"         Gastric emptying scintigraphy",
"        </strong>",
"        &ndash; For this test you eat food that has a small amount of a radioactive material in it. Then you have images taken of the inside of your body every hour for 4 hours. That way, doctors can follow where the food goes and how fast it gets there. If you still have a fair amount of food in your stomach after 4 hours, that means you have gastroparesis.",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H2420096\">",
"      <span class=\"h1\">",
"       Is there anything I can do on my own to feel better?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Yes. Some people feel better if they:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        Eat several small meals during the day instead of 2 or 3 big ones.",
"       </li>",
"       <li>",
"        Cut down on foods that have a lot of fat, such as cheese and fried foods.",
"       </li>",
"       <li>",
"        Cut down on foods that have a lot of fiber, such as fruits, vegetables, and beans.",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      If you have diabetes, it&rsquo;s also very important to keep your blood sugar as close to normal as possible.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H2420103\">",
"      <span class=\"h1\">",
"       Should I see a doctor or nurse?",
"      </span>",
"      &nbsp;&mdash;&nbsp;See your doctor or nurse if you have ongoing nausea or vomiting, belly pain, trouble eating, or weight loss.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H2420110\">",
"      <span class=\"h1\">",
"       How is gastroparesis treated?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Treatments can include:",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        <strong>",
"         Treatments to help you get the food and fluids you need",
"        </strong>",
"        &ndash; This might include taking liquid food supplements or&mdash;in rare cases&mdash;being fed through a tube.",
"       </li>",
"       <li>",
"        <strong>",
"         Medicines that make the stomach empty faster",
"        </strong>",
"       </li>",
"       <li>",
"        <strong>",
"         Medicines that help prevent nausea",
"        </strong>",
"       </li>",
"       <li>",
"        <strong>",
"         Emptying the stomach with a tube &ndash;",
"        </strong>",
"        To do this, doctors can put a tube down your throat or directly into your stomach through your skin.",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H2420207\">",
"      <span class=\"h1\">",
"       More on this topic",
"      </span>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?32/41/33426?source=see_link\">",
"       Patient information: Upper endoscopy (The Basics)",
"      </a>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?27/57/28562?source=see_link\">",
"       Patient information: Nausea and vomiting in adults (The Basics)",
"      </a>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?21/0/21506?source=see_link\">",
"       Patient information: Upper endoscopy (Beyond the Basics)",
"      </a>",
"     </p>",
"    </div>",
"    <div id=\"reviewProcess\">",
"     <span>",
"      All topics are updated as new evidence becomes available and our",
"      <a class=\"policy policy_editorialpolicy\" href=\"/home/editorial-policy\">",
"       peer review process",
"      </a>",
"      is complete.",
"     </span>",
"    </div>",
"    <div id=\"topicRetrievedDate\">",
"     <span class=\"emphasis\">",
"      This topic retrieved from UpToDate on:",
"     </span>",
"     Apr 20, 2013.",
"    </div>",
"    <div class=\"patTopicTool\" id=\"patTopicToolBottom\">",
"     <a class=\"toolbutton findicon findInPageLink\" href=\"#\" title=\"Find in Topic\">",
"      Find",
"     </a>",
"     <a class=\"toolbutton printicon\" href=\"UTD.htm?7/60/8130?view=print\" title=\"Print This Topic\">",
"      Print",
"     </a>",
"     <a class=\"toolbutton emailicon etacLink\" href=\"#\" title=\"Email This Topic\">",
"      Email",
"     </a>",
"    </div>",
"    <div id=\"disclaimer\">",
"     The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions.",
"The use of UpToDate content is governed by the",
"     <a class=\"legal legal_termsofuse\" href=\"/home/terms-use\" target=\"_blank\">",
"      UpToDate Terms of Use",
"     </a>",
"     . &copy;2013 UpToDate, Inc. All rights reserved.",
"    </div>",
"    <div id=\"topicVersionRevision\">",
"     Topic 16403 Version 2.0",
"    </div>",
"   </div>",
"   <!--  basicsTopicLeft -->",
"  </div>",
"  <!-- basicsTopicMinWidth -->",
" </div>",
" <!-- topicContent -->",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0605-61.234.146.186-A18C3F2596-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f7_60_8130=[""].join("\n");
var outline_f7_60_8130=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2420075\">",
"      What is gastroparesis?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2420082\">",
"      What are the symptoms of gastroparesis?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2420089\">",
"      Is there a test for gastroparesis?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2420096\">",
"      Is there anything I can do on my own to feel better?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2420103\">",
"      Should I see a doctor or nurse?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2420110\">",
"      How is gastroparesis treated?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2420207\">",
"      More on this topic",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PI/16403\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li>",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?28/27/29107\">",
"      Digestive system",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?27/57/28562?source=related_link\">",
"      Patient information: Nausea and vomiting in adults (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?21/0/21506?source=related_link\">",
"      Patient information: Upper endoscopy (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?32/41/33426?source=related_link\">",
"      Patient information: Upper endoscopy (The Basics)",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f7_60_8131="Looping during colonoscopy";
var content_f7_60_8131=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F82950&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F82950&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 554px\">",
"   <div class=\"ttl\">",
"    Looping during colonoscopy",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 534px; height: 364px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    (A)&nbsp;(on left) Shows a \"gamma\" loop in the transverse colon.",
"    <br>",
"     (B) (on right) Shows an \"alpha\" loop in the sigmoid colon.",
"     <div class=\"footnotes\">",
"     </div>",
"     <div class=\"reference\">",
"     </div>",
"    </br>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f7_60_8131=[""].join("\n");
var outline_f7_60_8131=null;
var title_f7_60_8132="Nephrology pattern 12 answer";
var content_f7_60_8132=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=NEPH%2F77678&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=NEPH%2F77678&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Nephrology pattern 12 answer",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 378px; height: 243px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Necrotizing glomerulonephritis. Light micrograph showing fresh segmental necrotizing lesions with bright red fibrin deposition (arrows). A necrotizing glomerulonephritis can be seen in a variety of inflammatory disorders including vasculitis and lupus nephritis. The latter has prominent immune complex deposition which is generally absent in vasculitis.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Helmut Rennke, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f7_60_8132=[""].join("\n");
var outline_f7_60_8132=null;
var title_f7_60_8133="Lomustine: Patient drug information";
var content_f7_60_8133=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Lomustine: Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"UTD.htm?36/27/37302?source=see_link\">",
"     see \"Lomustine: Drug information\"",
"    </a>",
"    and",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?15/34/15910?source=see_link\">",
"     see \"Lomustine: Pediatric drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F189599\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      CeeNU&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F189600\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      CeeNU&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt war-os drugH1Div\" id=\"F10027726\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warning",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700690",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       This drug may have unsafe effects on the bone marrow. The bone marrow may not be able to make cells found in the blood as well as it used to for a few weeks.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700602",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Sometimes drugs are not safe when you take them with certain other drugs. Taking them together can cause bad side effects. This is one of those drugs. Be sure to talk to your doctor about all the drugs you take.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F10027728\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691672",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat cancer.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F10027727\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2702405",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to lomustine or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701080",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are pregnant or may be pregnant.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701047",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are breast-feeding.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F10027732\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697282",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have kidney disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697290",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have liver disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698465",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Have your blood work checked. Talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697613",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with your doctor before getting any vaccines. Use with this drug may either raise the chance of an infection or make the vaccine not work as well.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697622",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with your doctor before using products that have aspirin, blood thinners, garlic, ginseng, ginkgo, ibuprofen or like products, pain drugs, or vitamin E.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697740",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Use birth control that you can trust to stop pregnancy while taking this drug.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F10027733\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698315",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       You may have more chance of getting an infection. Wash hands often. Stay away from people with infections, colds, or flu.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697877",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Anemia, low white blood cell count, and low platelet count. This drug may need to be stopped.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698275",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Upset stomach or throwing up. Many small meals, good mouth care, sucking hard, sugar-free candy, or chewing sugar-free gum may help. You may need drugs to lower this side effect. Talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698984",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Not hungry.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698226",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Harm to the lungs may happen.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F10027735\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698721",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you think there has been an overdose, call 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center (file://www.aapcc.org), or emergency room (ER) right away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699077",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of infection. These include a fever of 100.5&deg;F (38&deg;C) or higher, chills, very bad sore throat, ear or sinus pain, cough, more sputum or change in color of sputum, pain with passing urine, mouth sores, wound that will not heal, or anal itching or pain.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698640",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Trouble breathing.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699008",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad belly pain.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699058",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Change in thinking clearly and with logic.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699042",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very upset stomach or throwing up.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699019",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very loose stools (diarrhea).",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698981",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Not able to eat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699105",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any bruising or bleeding.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699094",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Swelling in your legs or belly.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698634",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Dark urine or yellow skin or eyes.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699104",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Not able to pass urine.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698658",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Feeling very tired or weak.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699049",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad skin irritation.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effect or health problem is not better or you are feeling worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F10027730\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696016",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is given as 1 dose every 6 weeks.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s4090024",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       The dose you get may be made up of 2 or more different strengths and colors of capsules.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695889",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take on an empty stomach. Take 2 hours before or 2 hours after meals.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696260",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Wear gloves when touching this drug.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyd-os drugH1Div\" id=\"F10027731\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I do if I miss a dose?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696446",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Call your doctor to find out what to do.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyi-os drugH1Div\" id=\"F10027736\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How do I store and/or throw out this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699336",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store at room temperature.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699266",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store in a dry place. Do not store in a bathroom.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F10027737\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 11387 Version 37.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-122.72.76.133-A3347AB727-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f7_60_8133=[""].join("\n");
var outline_f7_60_8133=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F189599\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F189600\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10027726\">",
"      Warning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10027728\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10027727\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10027732\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10027733\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10027735\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10027730\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10027731\">",
"      What do I do if I miss a dose?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10027736\">",
"      How do I store and/or throw out this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10027737\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?36/27/37302?source=related_link\">",
"      Lomustine: Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"UTD.htm?15/34/15910?source=related_link\">",
"      Lomustine: Pediatric drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f7_60_8134="Basic biology and epidemiology of sporotrichosis";
var content_f7_60_8134=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Basic biology and epidemiology of sporotrichosis",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?7/60/8134/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?7/60/8134/contributors\">",
"     Carol A Kauffman, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?7/60/8134/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?7/60/8134/contributors\">",
"     Kieren A Marr, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?7/60/8134/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?7/60/8134/contributors\">",
"     Anna R Thorner, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?7/60/8134/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Mar 22, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Sporotrichosis is a subacute to chronic infection caused by the dimorphic fungus Sporothrix schenckii. Infection usually involves cutaneous and subcutaneous tissues but can occasionally occur in other sites, primarily in immunocompromised patients. Activities associated with the development of sporotrichosis include landscaping, rose gardening, and other activities that involve inoculation of soil through the skin.",
"   </p>",
"   <p>",
"    The basic biology of S. schenckii and the epidemiology of sporotrichosis will be reviewed here. The clinical features, diagnosis, and treatment of this infection are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?12/11/12469?source=see_link\">",
"     \"Clinical features and diagnosis of sporotrichosis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?34/0/34822?source=see_link\">",
"     \"Treatment of sporotrichosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     MYCOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;S. schenckii is the primary pathogen in the genus Sporothrix [",
"    <a class=\"abstract\" href=\"UTD.htm?7/60/8134/abstract/1\">",
"     1",
"    </a>",
"    ]. S. schenckii var. luriei has been described as the cause of at least two cases of sporotrichosis [",
"    <a class=\"abstract\" href=\"UTD.htm?7/60/8134/abstract/2\">",
"     2",
"    </a>",
"    ]. This variety shows slight differences from S. schenckii in colony morphology, conidial structures, and yeast forms in tissue.",
"   </p>",
"   <p>",
"    Most laboratories still identify isolates as S. schenckii, but molecular studies have found that this species is actually made up of a complex of several different phylogenetic species that tend to cluster in different geographic regions [",
"    <a class=\"abstract\" href=\"UTD.htm?7/60/8134/abstract/3,4\">",
"     3,4",
"    </a>",
"    ]. At least four different clades, in addition to S. schenckii, have now been identified; these include S. brasiliensis and S. globosa, both of which have caused human infection, and S. mexicana and S. albicans, which have not been associated with infection in humans [",
"    <a class=\"abstract\" href=\"UTD.htm?7/60/8134/abstract/4\">",
"     4",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Dimorphism",
"    </span>",
"    &nbsp;&mdash;&nbsp;S. schenckii exhibits thermal dimorphism. It produces hyphae in the environment at temperatures that are lower than normal human body temperatures (",
"    <a class=\"graphic graphic_picture graphicRef81999 \" href=\"UTD.htm?18/37/19027\">",
"     picture 1",
"    </a>",
"    ) and exists as a yeast form when at 37&ordm;C in vitro and in human tissues [",
"    <a class=\"abstract\" href=\"UTD.htm?7/60/8134/abstract/1\">",
"     1",
"    </a>",
"    ]. Some strains are less thermotolerant than others, growing poorly at temperatures above 35&ordm;C; these strains tend to be found in fixed dermal lesions and do not have the propensity to spread along lymphatics into subcutaneous tissues as do most strains of S. schenckii [",
"    <a class=\"abstract\" href=\"UTD.htm?7/60/8134/abstract/5\">",
"     5",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Growth in vitro",
"    </span>",
"    &nbsp;&mdash;&nbsp;At 25&ordm;C to 27&ordm;C, the filamentous form of S. schenckii grows readily on standard media, such as Sabouraud agar. Within one to two weeks, growth begins as a white- to cream-colored mold and then assumes a brown, gray, or black color with further incubation (",
"    <a class=\"graphic graphic_picture graphicRef64948 \" href=\"UTD.htm?9/32/9743\">",
"     picture 2",
"    </a>",
"    ). With age, the colonies become wrinkled and, with repeated subculturing, may lose their dark color and turn off-white. The conidia may be dark-colored or hyaline, and arrange themselves along the hyphae in \"bouquet-like\" arrangements. The hyphae are thin, septate, and branched.",
"   </p>",
"   <p>",
"    Growth of the yeast phase in vitro requires incubation at 37&ordm;C on enriched media, such as brain heart infusion (BHI) agar. During yeast phase growth, the colonies are usually off-white and wrinkled.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Growth in vivo",
"    </span>",
"    &nbsp;&mdash;&nbsp;In human or animal tissues at 37&ordm;C, S. schenckii assumes a yeast-like form and reproduces by budding. The yeasts are usually 4 to 6 microns in diameter and variable in their shape; cigar-shaped yeast cells are classically described, but round and oval shaped yeast cells are also common.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Antigenic structure",
"    </span>",
"    &nbsp;&mdash;&nbsp;The cell wall of S. schenckii, as with most other pathogenic fungi, contains chitin, glucans, and mannans. However, unique to S. schenckii is the presence of L-rhamnose, in addition to mannose and glucose, as a major constituent of the glycopeptides in the cell wall [",
"    <a class=\"abstract\" href=\"UTD.htm?7/60/8134/abstract/6\">",
"     6",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h1\">",
"     VIRULENCE AND IMMUNE RESPONSE",
"    </span>",
"    &nbsp;&mdash;&nbsp;S. schenckii is generally not considered a highly virulent fungus. Disease in humans is usually localized to cutaneous and subcutaneous tissues and has a subacute to chronic course.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Experimental animal infection",
"    </span>",
"    &nbsp;&mdash;&nbsp;Laboratory rodents, including rats, mice, hamsters, and guinea pigs, can be infected with S. schenckii. Experimental infection mimics that seen naturally, usually causing localized infection.",
"   </p>",
"   <p>",
"    Those organisms that are isolated from fixed cutaneous lesions and that grow poorly at 37&ordm;C will multiply in colder areas, such as the testes, but rarely cause disseminated infection. Those strains that grow well at 37&ordm;C and have caused either extracutaneous or cutaneous lesions in humans spread and multiply in multiple internal organs, as well as the testes [",
"    <a class=\"abstract\" href=\"UTD.htm?7/60/8134/abstract/5\">",
"     5",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In a small study that involved the inoculation of mice with S. schenckii isolates from patients who had either disseminated or lymphocutaneous infection, differences in virulence depended on the type of infection in humans; only the isolates causing disseminated infection in humans were able to cause systemic infection and death in the mice [",
"    <a class=\"abstract\" href=\"UTD.htm?7/60/8134/abstract/7\">",
"     7",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?12/11/12469?source=see_link\">",
"     \"Clinical features and diagnosis of sporotrichosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Virulence factors",
"    </span>",
"    &nbsp;&mdash;&nbsp;The virulence factors of S. schenckii are not well understood. Several extracellular proteinases are capable of hydrolyzing collagen and elastin and might be important for pathogenicity [",
"    <a class=\"abstract\" href=\"UTD.htm?7/60/8134/abstract/8\">",
"     8",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    More intriguing data described the characteristics of isolates obtained from infected persons and from the presumed environmental source in a large multistate outbreak of sporotrichosis [",
"    <a class=\"abstract\" href=\"UTD.htm?7/60/8134/abstract/9\">",
"     9",
"    </a>",
"    ]. All of the organisms isolated from patients and only those environmental isolates that showed similar DNA typing patterns were able to grow at 37&ordm;C, were lethal for mice, and produced melanin, a documented virulence factor for other fungi [",
"    <a class=\"abstract\" href=\"UTD.htm?7/60/8134/abstract/10\">",
"     10",
"    </a>",
"    ]. Other environmental isolates were not pigmented and appeared to be nonvirulent.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Immune response",
"    </span>",
"    &nbsp;&mdash;&nbsp;Neutrophils, monocytes, and macrophages are capable of ingesting and killing the yeast phase of S. schenckii in the presence of nonimmune human serum [",
"    <a class=\"abstract\" href=\"UTD.htm?7/60/8134/abstract/11,12\">",
"     11,12",
"    </a>",
"    ]. Antibody appears to play an insignificant role in host protection.",
"   </p>",
"   <p>",
"    A role for T cells in containing infection is suggested by the observations that sporotrichosis is more severe in nude mice and that protection can be transferred by CD4 lymphocytes from immune mice [",
"    <a class=\"abstract\" href=\"UTD.htm?7/60/8134/abstract/13,14\">",
"     13,14",
"    </a>",
"    ]. In addition, the infection tends to disseminate widely in patients with HIV infection [",
"    <a class=\"abstract\" href=\"UTD.htm?7/60/8134/abstract/15,16\">",
"     15,16",
"    </a>",
"    ], a characteristic seen rarely in normal hosts.",
"   </p>",
"   <p>",
"    A role for cytokines, such as tumor necrosis factor (TNF)-alpha and interferon&ndash;gamma, has been noted in an experimental murine model of sporotrichosis and in one patient whose immunosuppressive therapy included the TNF-alpha antagonists,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?27/31/28151?source=see_link\">",
"     etanercept",
"    </a>",
"    and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?28/6/28776?source=see_link\">",
"     infliximab",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?7/60/8134/abstract/17\">",
"     17",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h1\">",
"     EPIDEMIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;S. schenckii is found worldwide in climates ranging from temperate to tropical. Most cases are reported from the Americas and Japan. Sporotrichosis is endemic in at least one remote area of Peru with a mean annual incidence of 73 cases per 100,000 adults and 156 cases per 100,000 children &lt;15 years of age [",
"    <a class=\"abstract\" href=\"UTD.htm?7/60/8134/abstract/18,19\">",
"     18,19",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Sources of infection",
"    </span>",
"    &nbsp;&mdash;&nbsp;S. schenckii exists in a variety of environmental niches that include sphagnum moss, decaying wood and other vegetation, hay, and soil. Thus, infection is most frequent in persons whose vocation or avocation brings them into contact with the environment.",
"   </p>",
"   <p>",
"    Activities associated with the development of sporotrichosis include landscaping, Christmas tree farming, rose gardening, topiary production, baling and using hay for packing materials or displays, and motor vehicle accidents that involve inoculation of soil into wounds [",
"    <a class=\"abstract\" href=\"UTD.htm?7/60/8134/abstract/9,20-24\">",
"     9,20-24",
"    </a>",
"    ]. In some cases, a discrete cutaneous inoculation site is not obvious, but the patient may recall exposure to soil, wood, or plant material.",
"   </p>",
"   <p>",
"    Inhalation of S. schenckii from soil is the presumed route of transmission for pulmonary sporotrichosis. Most patients have been involved in an occupation that exposes them to aerosols from soil, but specific sources are rarely identified.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Outbreaks",
"    </span>",
"    &nbsp;&mdash;&nbsp;The largest reported outbreak of sporotrichosis involved contaminated timber in gold mines in Witwatersrand, South Africa [",
"    <a class=\"abstract\" href=\"UTD.htm?7/60/8134/abstract/25\">",
"     25",
"    </a>",
"    ]. Over a three year period, nearly 3000 workers developed sporotrichosis, presumably after direct inoculation of the organism from wood splinters.",
"   </p>",
"   <p>",
"    The largest outbreak in the United States involved 84 patients in 15 states and was traced back to conifer seedlings that had been packed in sphagnum moss obtained from Wisconsin [",
"    <a class=\"abstract\" href=\"UTD.htm?7/60/8134/abstract/9,10\">",
"     9,10",
"    </a>",
"    ]. Other outbreaks in the United States also have been traced back to Wisconsin sphagnum moss [",
"    <a class=\"abstract\" href=\"UTD.htm?7/60/8134/abstract/20,21\">",
"     20,21",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Zoonotic transmission",
"    </span>",
"    &nbsp;&mdash;&nbsp;Zoonotic transmission of sporotrichosis is uncommon, but has been traced to a variety of animals [",
"    <a class=\"abstract\" href=\"UTD.htm?7/60/8134/abstract/26-34\">",
"     26-34",
"    </a>",
"    ]. Most cases of transmission from animals to humans have been associated with cats [",
"    <a class=\"abstract\" href=\"UTD.htm?7/60/8134/abstract/19,26,28,29\">",
"     19,26,28,29",
"    </a>",
"    ]. In the highly endemic area in Peru, risk factors for infection among children were playing in fields, living in houses with dirt floors, and owning a cat [",
"    <a class=\"abstract\" href=\"UTD.htm?7/60/8134/abstract/19\">",
"     19",
"    </a>",
"    ]. An outbreak in Rio de Janeiro, Brazil that began around 1998, and continues still, is related primarily to domestic cats [",
"    <a class=\"abstract\" href=\"UTD.htm?7/60/8134/abstract/26,29,34\">",
"     26,29,34",
"    </a>",
"    ]. This outbreak has involved several thousand people and appears to have originated from a common source [",
"    <a class=\"abstract\" href=\"UTD.htm?7/60/8134/abstract/35\">",
"     35",
"    </a>",
"    ]. &nbsp;Most infections have been reported from poor neighborhoods and have been seen predominantly in women and children, who were most likely to care for and play with cats [",
"    <a class=\"abstract\" href=\"UTD.htm?7/60/8134/abstract/26\">",
"     26",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    An analysis of 347 cats involved in this outbreak revealed that most had cutaneous lesions on the head with frequent mucosal involvement, and 44 percent had signs of respiratory tract involvement [",
"    <a class=\"abstract\" href=\"UTD.htm?7/60/8134/abstract/29\">",
"     29",
"    </a>",
"    ]. Dogs were also infected during this outbreak and also had a predominance of facial and nasal mucous membrane lesions [",
"    <a class=\"abstract\" href=\"UTD.htm?7/60/8134/abstract/30\">",
"     30",
"    </a>",
"    ]. Sporotrichosis is an occupational hazard for veterinarians treating infected pet cats [",
"    <a class=\"abstract\" href=\"UTD.htm?7/60/8134/abstract/28\">",
"     28",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In Uruguay, a common history is that of a patient who describes hunting armadillos, receives scratches from the animal, and later develops skin lesions. In these cases, the armadillo is not infected, but inoculates S. schenckii, which is present in nesting materials and the soil, into the skin [",
"    <a class=\"abstract\" href=\"UTD.htm?7/60/8134/abstract/27\">",
"     27",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Other cases have been ascribed to inoculation of the organism by insect stings, bird pecks, rodent bites, and by handling fish [",
"    <a class=\"abstract\" href=\"UTD.htm?7/60/8134/abstract/26,28,31-33,36\">",
"     26,28,31-33,36",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Laboratory-acquired sporotrichosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Several cases of sporotrichosis have been described in laboratory workers handling experimentally infected animals or culture materials [",
"    <a class=\"abstract\" href=\"UTD.htm?7/60/8134/abstract/37\">",
"     37",
"    </a>",
"    ]. Most cases involved cutaneous inoculation of infectious material, but ocular involvement occurred in several cases after infectious material was splashed into the eye.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Sporotrichosis is a subacute to chronic infection caused by the dimorphic fungus Sporothrix schenckii. Infection usually involves cutaneous and subcutaneous tissues but can occasionally occur in other sites, primarily in immunocompromised patients. Activities associated with the development of sporotrichosis include landscaping, rose gardening, and other activities that involve inoculation of soil through the skin. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Most laboratories still identify isolates as S. schenckii, but molecular studies have found that this species is actually made up of a complex of several different phylogenetic species that tend to cluster in different geographic regions. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Mycology'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      S. schenckii exhibits thermal dimorphism since it produces hyphae in the environment at temperatures that are lower than normal human body temperatures (",
"      <a class=\"graphic graphic_picture graphicRef81999 \" href=\"UTD.htm?18/37/19027\">",
"       picture 1",
"      </a>",
"      ) and exists as a yeast form when at 37&ordm;C in vitro and in human tissues. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Dimorphism'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      S. schenckii is found worldwide in climates ranging from temperate to tropical. Most cases are reported from the Americas and Japan. (See",
"      <a class=\"local\" href=\"#H11\">",
"       'Epidemiology'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      S. schenckii exists in a variety of environmental niches that include sphagnum moss, decaying wood and other vegetation, hay, and soil. Thus, infection is most frequent in persons whose vocation or avocation brings them into contact with the environment. In some cases, a discrete cutaneous inoculation site is not obvious, but the patient may recall exposure to soil, wood, or plant material. Inhalation of S. schenckii from soil is the presumed route of transmission for pulmonary sporotrichosis. (See",
"      <a class=\"local\" href=\"#H12\">",
"       'Sources of infection'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Zoonotic transmission of sporotrichosis is uncommon, but has been traced back to a variety of animals. Most cases of transmission from animals to humans have been associated with cats. An ongoing outbreak in Rio de Janeiro involving several thousand persons has been attributed to infected cats. (See",
"      <a class=\"local\" href=\"#H14\">",
"       'Zoonotic transmission'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     Kwon-Chung KJ, Bennett JE. Sporotrichosis. In: Medical Mycology, Kwon-Chung KJ, Bennett JE (Eds), Lea &amp; Febiger, Philadelphia 1992. p.707.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/60/8134/abstract/2\">",
"      Alberici F, Paties CT, Lombardi G, et al. Sporothrix schenckii var luriei as the cause of sporotrichosis in Italy. Eur J Epidemiol 1989; 5:173.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/60/8134/abstract/3\">",
"      Marimon R, Gen&eacute; J, Cano J, et al. Molecular phylogeny of Sporothrix schenckii. J Clin Microbiol 2006; 44:3251.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/60/8134/abstract/4\">",
"      Marimon R, Cano J, Gen&eacute; J, et al. Sporothrix brasiliensis, S. globosa, and S. mexicana, three new Sporothrix species of clinical interest. J Clin Microbiol 2007; 45:3198.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/60/8134/abstract/5\">",
"      Kwon-Chung KJ. Comparison of isolates of Sporothrix schenckii obtained from fixed cutaneous lesions with isolates from other types of lesions. J Infect Dis 1979; 139:424.",
"     </a>",
"    </li>",
"    <li>",
"     Reiss E. Cell wall composition. In: Fungi Pathogenic for Humans and Animals, Part B: Pathogenicity and Detection, Howard DH (Ed), Marcel Dekker, New York 1985. p.57.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/60/8134/abstract/7\">",
"      Brito MM, Concei&ccedil;&atilde;o-Silva F, Morgado FN, et al. Comparison of virulence of different Sporothrix schenckii clinical isolates using experimental murine model. Med Mycol 2007; 45:721.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/60/8134/abstract/8\">",
"      Tsuboi R, Sanada T, Takamori K, Ogawa H. Isolation and properties of extracellular proteinases from Sporothrix schenckii. J Bacteriol 1987; 169:4104.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/60/8134/abstract/9\">",
"      Dixon DM, Salkin IF, Duncan RA, et al. Isolation and characterization of Sporothrix schenckii from clinical and environmental sources associated with the largest U.S. epidemic of sporotrichosis. J Clin Microbiol 1991; 29:1106.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/60/8134/abstract/10\">",
"      Dixon DM, Duncan RA, Hurd NJ. Use of a mouse model to evaluate clinical and environmental isolates of Sporothrix spp. from the largest U.S. epidemic of sporotrichosis. J Clin Microbiol 1992; 30:951.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/60/8134/abstract/11\">",
"      Cunningham KM, Bulmer GS, Rhoades ER. Phagocytosis and intracellular fate of Sporothrix schenckii. J Infect Dis 1979; 140:815.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/60/8134/abstract/12\">",
"      Rex JH, Bennett JE. Administration of potassium iodide to normal volunteers does not increase killing of Sporothrix schenckii by their neutrophils or monocytes. J Med Vet Mycol 1990; 28:185.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/60/8134/abstract/13\">",
"      Shiraishi A, Nakagaki K, Arai T. Role of cell-mediated immunity in the resistance to experimental sporotrichosis in mice. Mycopathologia 1992; 120:15.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/60/8134/abstract/14\">",
"      Tachibana T, Matsuyama T, Mitsuyama M. Involvement of CD4+ T cells and macrophages in acquired protection against infection with Sporothrix schenckii in mice. Med Mycol 1999; 37:397.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/60/8134/abstract/15\">",
"      Bolao F, Podzamczer D, Ventin M, Gudiol F. Efficacy of acute phase and maintenance therapy with itraconazole in an AIDS patient with sporotrichosis. Eur J Clin Microbiol Infect Dis 1994; 13:609.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/60/8134/abstract/16\">",
"      Freitas DF, de Siqueira Hoagland B, do Valle AC, et al. Sporotrichosis in HIV-infected patients: report of 21 cases of endemic sporotrichosis in Rio de Janeiro, Brazil. Med Mycol 2012; 50:170.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/60/8134/abstract/17\">",
"      Gottlieb, GS, Lesser, CF, Holmes, KK, Wald, A. Disseminated sporotrichosis associated with treatment with immunosuppressants and tumor necrosis factor&ndash;alpha antagonists. Clin Infect Dis 2003; 37:638.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/60/8134/abstract/18\">",
"      Pappas PG, Tellez I, Deep AE, et al. Sporotrichosis in Peru: description of an area of hyperendemicity. Clin Infect Dis 2000; 30:65.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/60/8134/abstract/19\">",
"      Lyon GM, Zurita S, Casquero J, et al. Population-based surveillance and a case-control study of risk factors for endemic lymphocutaneous sporotrichosis in Peru. Clin Infect Dis 2003; 36:34.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/60/8134/abstract/20\">",
"      Powell KE, Taylor A, Phillips BJ, et al. Cutaneous sporotrichosis in forestry workers. Epidemic due to contaminated Sphagnum moss. JAMA 1978; 240:232.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/60/8134/abstract/21\">",
"      Hajjeh R, McDonnell S, Reef S, et al. Outbreak of sporotrichosis among tree nursery workers. J Infect Dis 1997; 176:499.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/60/8134/abstract/22\">",
"      Sanders E. Cutaneous sporotrichosis. Beer, bricks, and bumps. Arch Intern Med 1971; 127:482.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/60/8134/abstract/23\">",
"      Centers for Disease Control (CDC). Sporotrichosis among hay-mulching workers--Oklahoma, New Mexico. MMWR Morb Mortal Wkly Rep 1984; 33:682.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/60/8134/abstract/24\">",
"      Dooley DP, Bostic PS, Beckius ML. Spook house sporotrichosis. A point-source outbreak of sporotrichosis associated with hay bale props in a Halloween haunted-house. Arch Intern Med 1997; 157:1885.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/60/8134/abstract/25\">",
"      LURIE HI. Five unusual cases of sporotrichosis from South Africa showing lesions in muscles, bones, and viscera. Br J Surg 1963; 50:585.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/60/8134/abstract/26\">",
"      Barros MB, Schubach Ade O, do Valle AC, et al. Cat-transmitted sporotrichosis epidemic in Rio de Janeiro, Brazil: description of a series of cases. Clin Infect Dis 2004; 38:529.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/60/8134/abstract/27\">",
"      Conti D&iacute;az IA. Epidemiology of sporotrichosis in Latin America. Mycopathologia 1989; 108:113.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/60/8134/abstract/28\">",
"      Reed KD, Moore FM, Geiger GE, Stemper ME. Zoonotic transmission of sporotrichosis: case report and review. Clin Infect Dis 1993; 16:384.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/60/8134/abstract/29\">",
"      Schubach TM, Schubach A, Okamoto T, et al. Evaluation of an epidemic of sporotrichosis in cats: 347 cases (1998-2001). J Am Vet Med Assoc 2004; 224:1623.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/60/8134/abstract/30\">",
"      Schubach TM, Schubach A, Okamoto T, et al. Canine sporotrichosis in Rio de Janeiro, Brazil: clinical presentation, laboratory diagnosis and therapeutic response in 44 cases (1998-2003). Med Mycol 2006; 44:87.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/60/8134/abstract/31\">",
"      Frean JA, Isa&auml;cson M, Miller GB, et al. Sporotrichosis following a rodent bite. A case report. Mycopathologia 1991; 116:5.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/60/8134/abstract/32\">",
"      Saravanakumar PS, Eslami P, Zar FA. Lymphocutaneous sporotrichosis associated with a squirrel bite: case report and review. Clin Infect Dis 1996; 23:647.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/60/8134/abstract/33\">",
"      Haddad VJ, Miot HA, Bartoli LD, et al. Localized lymphatic sporotrichosis after fish-induced injury (Tilapia sp.). Med Mycol 2002; 40:425.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/60/8134/abstract/34\">",
"      Freitas DF, do Valle AC, de Almeida Paes R, et al. Zoonotic Sporotrichosis in Rio de Janeiro, Brazil: a protracted epidemic yet to be curbed. Clin Infect Dis 2010; 50:453.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/60/8134/abstract/35\">",
"      Galhardo MC, De Oliveira RM, Valle AC, et al. Molecular epidemiology and antifungal susceptibility patterns of Sporothrix schenckii isolates from a cat-transmitted epidemic of sporotrichosis in Rio de Janeiro, Brazil. Med Mycol 2008; 46:141.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/60/8134/abstract/36\">",
"      Naqvi SH, Becherer P, Gudipati S. Ketoconazole treatment of a family with zoonotic sporotrichosis. Scand J Infect Dis 1993; 25:543.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/60/8134/abstract/37\">",
"      Cooper CR, Dixon DM, Salkin IF. Laboratory-acquired sporotrichosis. J Med Vet Mycol 1992; 30:169.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 2433 Version 4.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-221.10.40.232-29E1B55F6D-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f7_60_8134=[""].join("\n");
var outline_f7_60_8134=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H16\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      MYCOLOGY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Dimorphism",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Growth in vitro",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Growth in vivo",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Antigenic structure",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      VIRULENCE AND IMMUNE RESPONSE",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Experimental animal infection",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Virulence factors",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Immune response",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      EPIDEMIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Sources of infection",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Outbreaks",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Zoonotic transmission",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Laboratory-acquired sporotrichosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"ID/2433\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ID/2433|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?18/37/19027\" title=\"picture 1\">",
"      Hyphal form of Sporothrix",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?9/32/9743\" title=\"picture 2\">",
"      Sporotric mold 25 degrees C",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?12/11/12469?source=related_link\">",
"      Clinical features and diagnosis of sporotrichosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?34/0/34822?source=related_link\">",
"      Treatment of sporotrichosis",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f7_60_8135="Stenotrophomonas maltophilia";
var content_f7_60_8135=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"4\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Stenotrophomonas maltophilia",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?7/60/8135/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?7/60/8135/contributors\">",
"     Sarah Stamps Lewis, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?7/60/8135/contributors\">",
"     Aimee Zaas, MD, MHS",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?7/60/8135/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?7/60/8135/contributors\">",
"     Daniel J Sexton, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?7/60/8135/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?7/60/8135/contributors\">",
"     Allyson Bloom, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?7/60/8135/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Nov 15, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H47084643\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Stenotrophomonas maltophilia is a multi-drug resistant gram-negative bacillus that is an opportunistic pathogen [",
"    <a class=\"abstract\" href=\"UTD.htm?7/60/8135/abstract/1-4\">",
"     1-4",
"    </a>",
"    ], particularly among hospitalized patients. Stenotrophomonas infections have been associated with high morbidity and mortality in severely immunocompromised and debilitated individuals. &nbsp;",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H47084650\">",
"    <span class=\"h1\">",
"     MICROBIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Stenotrophomonas (Xanthomonas) maltophilia is a ubiquitous, aerobic, non-fermentative, gram-negative bacillus that is closely related to the Pseudomonas species [",
"    <a class=\"abstract\" href=\"UTD.htm?7/60/8135/abstract/5\">",
"     5",
"    </a>",
"    ]. The name signifies &ldquo;a unit feeding on few substrates,&rdquo; based on the Greek roots stenos (narrow), trophos (one who feeds), and monas (a unit). Maltophilia means &ldquo;affinity for malt,&rdquo; based on the Greek roots maltum (malt) and philia (affinity).",
"   </p>",
"   <p>",
"    S. maltophilia was first isolated in 1943 and, at the time, was named Bacterium bookeri. It was later classified within the genus Pseudomonas, then Xanthomonas, and then finally Stenotrophomonas in 1993 [",
"    <a class=\"abstract\" href=\"UTD.htm?7/60/8135/abstract/4,6,7\">",
"     4,6,7",
"    </a>",
"    ]. S. maltophilia is the only species of Stenotrophomonas known to infect humans [",
"    <a class=\"abstract\" href=\"UTD.htm?7/60/8135/abstract/7\">",
"     7",
"    </a>",
"    ], whereas its closest genetic relatives are plant pathogens [",
"    <a class=\"abstract\" href=\"UTD.htm?7/60/8135/abstract/7,8\">",
"     7,8",
"    </a>",
"    ]. It is frequently isolated from soil, water, animals, plant matter, and hospital equipment [",
"    <a class=\"abstract\" href=\"UTD.htm?7/60/8135/abstract/4,9-21\">",
"     4,9-21",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    S. maltophilia has inherent ability to adhere to foreign materials and form a biofilm, rendering protection from host defenses as well as antimicrobial agents [",
"    <a class=\"abstract\" href=\"UTD.htm?7/60/8135/abstract/18,19,22-26\">",
"     18,19,22-26",
"    </a>",
"    ]. Factors contributing to this behavior include its positively charged surface and fimbrial adhesions [",
"    <a class=\"abstract\" href=\"UTD.htm?7/60/8135/abstract/7,22-24,26-28\">",
"     7,22-24,26-28",
"    </a>",
"    ]. In addition, Stenotrophomonas has intrinsic or acquired resistance mechanisms to a number of antibiotic classes, including beta-lactams, aminoglycosides, carbapenems, and fluoroquinolones. Resistance to beta-lactams is conferred by two inducible beta-lactamases, a zinc-containing penicillinase (L1) and a cephalosporinase (L2) [",
"    <a class=\"abstract\" href=\"UTD.htm?7/60/8135/abstract/21,29-32\">",
"     21,29-32",
"    </a>",
"    ]. An aminoglycoside acetyl-transferase confers resistance to aminoglycoside antibiotics [",
"    <a class=\"abstract\" href=\"UTD.htm?7/60/8135/abstract/33-39\">",
"     33-39",
"    </a>",
"    ]. Temperature-dependent changes in the outer membrane lipopolysaccharide (LPS) structure have been associated with added resistance to aminoglycoside antibiotics [",
"    <a class=\"abstract\" href=\"UTD.htm?7/60/8135/abstract/18,40-43\">",
"     18,40-43",
"    </a>",
"    ]. In addition, many strains of S. maltophilia possess efflux pumps, which confer further resistance to multiple antibacterial classes [",
"    <a class=\"abstract\" href=\"UTD.htm?7/60/8135/abstract/33,44-47\">",
"     33,44-47",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H47084657\">",
"    <span class=\"h1\">",
"     EPIDEMIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Stenotrophomonas infections have been associated with high morbidity and mortality in severely immunocompromised and debilitated individuals. Risk factors associated with Stenotrophomonas infection include admission to an intensive care unit, HIV infection, malignancy, cystic fibrosis, neutropenia, mechanical ventilation, central venous catheters, recent surgery, trauma, and previous therapy with broad-spectrum antibiotics [",
"    <a class=\"abstract\" href=\"UTD.htm?7/60/8135/abstract/1,2,4,20,21,48-51\">",
"     1,2,4,20,21,48-51",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The reported incidence of Stenotrophomonas maltophilia infections ranges from 7.1 to 37.7 cases per 10,000 discharges [",
"    <a class=\"abstract\" href=\"UTD.htm?7/60/8135/abstract/4,33,49,52\">",
"     4,33,49,52",
"    </a>",
"    ]. The frequency of Stenotrophomonas infections seems to be increasing as the population of patients at risk increases. This increase is probably due to advances in the treatment of malignancy, increased use of invasive devices, and widespread use of broad-spectrum antibiotics [",
"    <a class=\"abstract\" href=\"UTD.htm?7/60/8135/abstract/1,4,48,51,53,54\">",
"     1,4,48,51,53,54",
"    </a>",
"    ]. Strict hand hygiene and contact isolation procedures have been utilized to reduce clonal spread in the ICU setting [",
"    <a class=\"abstract\" href=\"UTD.htm?7/60/8135/abstract/55\">",
"     55",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Stenotrophomonas infections are associated with significant mortality; estimates range from 21 to 69 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?7/60/8135/abstract/51,56,57\">",
"     51,56,57",
"    </a>",
"    ]. However, the actual mortality attributed to these infections when controlling for other variables is unclear. Retrospective analyses have sought to identify independent risk factors associated with mortality in patients infected with Stenotrophomonas; in one retrospective cohort study, admission to an intensive care unit and delay in effective treatment were found to be independent risk factors for mortality [",
"    <a class=\"abstract\" href=\"UTD.htm?7/60/8135/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2963639\">",
"    <span class=\"h1\">",
"     CLINICAL MANIFESTATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pneumonia and bacteremia are the most common manifestations of infection [",
"    <a class=\"abstract\" href=\"UTD.htm?7/60/8135/abstract/2,4,33,53,58-62\">",
"     2,4,33,53,58-62",
"    </a>",
"    ]. In a surveillance study including 842 Stenotrophomonas isolates collected from over 60 hospitals, the prevalence of S. maltophilia among respiratory and blood isolates was 3.3 and 0.8 percent, respectively [",
"    <a class=\"abstract\" href=\"UTD.htm?7/60/8135/abstract/58\">",
"     58",
"    </a>",
"    ]. Less common manifestations of Stenotrophomonas infections include endocarditis, mastoiditis, peritonitis, meningitis,",
"    <sup>",
"    </sup>",
"    soft tissue infection, wound infection, urinary tract infection, and ocular infection [",
"    <a class=\"abstract\" href=\"UTD.htm?7/60/8135/abstract/2,4,33,53,59-62\">",
"     2,4,33,53,59-62",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    S. maltophilia can adhere to the mucosal surfaces of the upper airway and large bronchi and may colonize these areas without causing infection. In some cases discerning between colonization and infection can be clinically challenging. In the absence of consolidation on chest radiography, a positive respiratory tract isolate of Stenotrophomonas probably represents colonization rather than invasive disease. In a retrospective review of 92 patients presenting with acute respiratory symptoms and subsequently found to have respiratory cultures positive for S. maltophilia, there was no measurable impact of antibiotic therapy in the absence of chest radiograph consolidation [",
"    <a class=\"abstract\" href=\"UTD.htm?7/60/8135/abstract/63\">",
"     63",
"    </a>",
"    ]. In the presence of evidence for consolidation on chest radiography, definitively distinguishing between pneumonia due to S. maltophilia and pneumonia due to other causes may not be possible.",
"   </p>",
"   <p>",
"    Similarly, Stenotrophomonas may also be recovered from other non-sterile sites, including urinary catheters, surgical drains, and vascular catheter hubs. In the absence of bacteremia or evidence of infection in other sterile site (such as pleural fluid, peritoneal fluid), such culture findings may be presumed to reflect colonization rather than infection.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H47084664\">",
"    <span class=\"h1\">",
"     TREATMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;Clinically, it can be difficult to differentiate colonization from true infection due to Stenotrophomonas, although delay in appropriate treatment and use of inappropriate antibiotics can add to significant mortality. The decision regarding the need for antimicrobial therapy is based on a combination of clinical assessment and culture data.",
"   </p>",
"   <p>",
"    In patients with clinical evidence of pneumonia, cultures growing Stenotrophomonas from respiratory sites should be interpreted to represent true infection. Similarly, cultures growing Stenotrophomonas from normally sterile sites (such as blood or peritoneal fluid) should be interpreted to represent true infection. However, clinicians must use caution when interpreting culture data obtained from non-sterile sites such as indwelling urinary catheters or drains, given the organism&rsquo;s propensity to colonize foreign materials. In these situations, the assessment for clinical evidence of infection (eg, fever, leukocytosis, localized pain) is critical.",
"   </p>",
"   <p>",
"    Clinical data are limited regarding optimal therapy for infections caused by Stenotrophomonas, and treatment can be challenging due to its intrinsic resistance to multiple antibiotics [",
"    <a class=\"abstract\" href=\"UTD.htm?7/60/8135/abstract/4,53,62,64\">",
"     4,53,62,64",
"    </a>",
"    ]. Furthermore, there are uncertainties regarding the optimal approach to in vitro susceptibility testing given discrepancies between results of various methods [",
"    <a class=\"abstract\" href=\"UTD.htm?7/60/8135/abstract/49,53,59,65\">",
"     49,53,59,65",
"    </a>",
"    ]. The US Clinical and Laboratory Standards Institute (CLSI) has published disc-diffusion MIC breakpoints (for",
"    <a class=\"drug drug_general\" href=\"UTD.htm?4/58/5034?source=see_link\">",
"     trimethoprim-sulfamethoxazole",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?3/10/3240?source=see_link\">",
"     minocycline",
"    </a>",
"    , and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?32/46/33504?source=see_link\">",
"     levofloxacin",
"    </a>",
"    ) and broth dilution MIC breakpoints (for ticarcillin-clavulanic acid,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?17/0/17415?source=see_link\">",
"     ceftazidime",
"    </a>",
"    , minocycline, levofloxacin, and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?1/54/1897?source=see_link\">",
"     chloramphenicol",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?7/60/8135/abstract/18,53,66,67\">",
"     18,53,66,67",
"    </a>",
"    ]. Etest may be used for evaluation of ceftazidime, minocycline, and chloramphenicol susceptibility. Resistance to carbapenems should be presumed regardless of testing results. There are no MIC interpretive criteria for",
"    <a class=\"drug drug_general\" href=\"UTD.htm?2/49/2840?source=see_link\">",
"     tetracycline",
"    </a>",
"    or",
"    <a class=\"drug drug_general\" href=\"UTD.htm?39/7/40053?source=see_link\">",
"     tigecycline",
"    </a>",
"    .",
"   </p>",
"   <p>",
"    <a class=\"drug drug_general\" href=\"UTD.htm?4/58/5034?source=see_link\">",
"     Trimethoprim-sulfamethoxazole",
"    </a>",
"    (TMP-SMX) is favored as the treatment of choice for serious infections caused by Stenotrophomonas, based on its in vitro activity and anecdotal reports of favorable clinical outcomes [",
"    <a class=\"abstract\" href=\"UTD.htm?7/60/8135/abstract/53,68,69\">",
"     53,68,69",
"    </a>",
"    ]. However, there are reports of TMP-SMX resistance [",
"    <a class=\"abstract\" href=\"UTD.htm?7/60/8135/abstract/4,53,58,60,64,69\">",
"     4,53,58,60,64,69",
"    </a>",
"    ]. The duration of therapy depends on the site of the infection; 14 days of therapy is appropriate for bacteremia or hospital acquired pneumonia, in the setting of evidence for clinical improvement. (See appropriate topic reviews for discussion regarding the duration of therapy for specific infections).",
"   </p>",
"   <p>",
"    Ticarcillin-clavulanic acid has been proposed as an alternate therapeutic agent, although rates of in vitro resistance are reported to be as high as 54.7 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?7/60/8135/abstract/18,33,70\">",
"     18,33,70",
"    </a>",
"    ].",
"    <sup>",
"    </sup>",
"    Other agents with in vitro activity against Stenotrophomonas include",
"    <a class=\"drug drug_general\" href=\"UTD.htm?17/0/17415?source=see_link\">",
"     ceftazidime",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?32/46/33504?source=see_link\">",
"     levofloxacin",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?32/51/33584?source=see_link\">",
"     moxifloxacin",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?3/10/3240?source=see_link\">",
"     minocycline",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?39/7/40053?source=see_link\">",
"     tigecycline",
"    </a>",
"    , polymyxins (ie,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?42/14/43238?source=see_link\">",
"     colistin",
"    </a>",
"    sulfate), and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?10/31/10746?source=see_link\">",
"     rifampin",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?7/60/8135/abstract/18,53,66,71-74\">",
"     18,53,66,71-74",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The role of combination therapy for treatment of serious Stenotrophomonas infections is uncertain. Several groups have reported in vitro synergy for combinations of antibiotics including TMP-SMX plus",
"    <a class=\"drug drug_general\" href=\"UTD.htm?17/0/17415?source=see_link\">",
"     ceftazidime",
"    </a>",
"    , TMP-SMX plus ticarcillin-clavulanic acid, and ticarcillin-clavulanic acid plus",
"    <a class=\"drug drug_general\" href=\"UTD.htm?34/45/35536?source=see_link\">",
"     ciprofloxacin",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?7/60/8135/abstract/75-77\">",
"     75-77",
"    </a>",
"    ]. Thus far, clinical data regarding benefit of combination therapy are lacking. Nonetheless, combination therapy may be appropriate for severely immunocompromised or neutropenic patients prior to the availability of susceptibility testing results or in institutions known to have a high rate of infections with Stenotrophomonas resistant to TMP-SMX [",
"    <a class=\"abstract\" href=\"UTD.htm?7/60/8135/abstract/33,53,65,68,69\">",
"     33,53,65,68,69",
"    </a>",
"    ]. Subsequently, antibiotic therapy can be tailored to susceptibility data and clinical improvement.",
"   </p>",
"   <p>",
"    Infection control measures are important to minimize the incidence of Stenotrophomonas infections and for reducing emergence of resistant strains. These measures include appropriate use of antibiotics, avoidance of prolonged or unnecessary use of foreign devices, and adherence to hand hygiene practices. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/12/19658?source=see_link\">",
"     \"General principles of infection control\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2964717\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Stenotrophomonas maltophilia is a multi-drug resistant gram-negative bacillus that is emerging as an opportunistic pathogen. It has inherent ability to adhere to foreign materials and form a biofilm, rendering protection from host defenses as well as antimicrobial agents. In addition, Stenotrophomonas has intrinsic or acquired resistance mechanisms to a number of antibiotic classes. (See",
"      <a class=\"local\" href=\"#H47084650\">",
"       'Microbiology'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Stenotrophomonas infections have been associated with high morbidity and mortality in severely immunocompromised and debilitated individuals. Risk factors associated with Stenotrophomonas infection include admission to an intensive care unit, HIV infection, malignancy, cystic fibrosis, neutropenia, mechanical ventilation, central venous catheters, recent surgery, trauma, and previous therapy with broad-spectrum antibiotics. (See",
"      <a class=\"local\" href=\"#H47084657\">",
"       'Epidemiology'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Pneumonia and bacteremia are the most common manifestations of Stenotrophomonas infection. Less common manifestations include endocarditis, mastoiditis, peritonitis, meningitis,",
"      <sup>",
"      </sup>",
"      soft tissue infection, wound infection, urinary tract infection, and ocular infection. (See",
"      <a class=\"local\" href=\"#H2963639\">",
"       'Clinical manifestations'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      We suggest",
"      <a class=\"drug drug_general\" href=\"UTD.htm?4/58/5034?source=see_link\">",
"       trimethoprim-sulfamethoxazole",
"      </a>",
"      (TMP-SMX) for treatment of infection due to Stenotrophomonas (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). The duration of therapy depends on the site of infection. Other agents with in vitro activity against Stenotrophomonas include",
"      <a class=\"drug drug_general\" href=\"UTD.htm?17/0/17415?source=see_link\">",
"       ceftazidime",
"      </a>",
"      , ticarcillin-clavulanic acid,",
"      <a class=\"drug drug_general\" href=\"UTD.htm?32/46/33504?source=see_link\">",
"       levofloxacin",
"      </a>",
"      ,",
"      <a class=\"drug drug_general\" href=\"UTD.htm?32/51/33584?source=see_link\">",
"       moxifloxacin",
"      </a>",
"      ,",
"      <a class=\"drug drug_general\" href=\"UTD.htm?3/10/3240?source=see_link\">",
"       minocycline",
"      </a>",
"      ,",
"      <a class=\"drug drug_general\" href=\"UTD.htm?39/7/40053?source=see_link\">",
"       tigecycline",
"      </a>",
"      , polymyxins (ie,",
"      <a class=\"drug drug_general\" href=\"UTD.htm?42/14/43238?source=see_link\">",
"       colistin",
"      </a>",
"      sulfate), and",
"      <a class=\"drug drug_general\" href=\"UTD.htm?10/31/10746?source=see_link\">",
"       rifampin",
"      </a>",
"      . (See",
"      <a class=\"local\" href=\"#H47084664\">",
"       'Treatment'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Infection control measures are important to minimize the incidence of Stenotrophomonas infections and for reducing emergence of resistant strains. These measures include appropriate use of antibiotics, avoidance of prolonged or unnecessary use of foreign devices, and adherence to hand hygiene practices (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?19/12/19658?source=see_link\">",
"       \"General principles of infection control\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/60/8135/abstract/1\">",
"      Paez JI, Tengan FM, Barone AA, et al. Factors associated with mortality in patients with bloodstream infection and pneumonia due to Stenotrophomonas maltophilia. Eur J Clin Microbiol Infect Dis 2008; 27:901.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/60/8135/abstract/2\">",
"      Kwa AL, Low JG, Lim TP, et al. Independent predictors for mortality in patients with positive Stenotrophomonas maltophilia cultures. Ann Acad Med Singapore 2008; 37:826.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/60/8135/abstract/3\">",
"      Lai CH, Chi CY, Chen HP, et al. Clinical characteristics and prognostic factors of patients with Stenotrophomonas maltophilia bacteremia. J Microbiol Immunol Infect 2004; 37:350.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/60/8135/abstract/4\">",
"      Denton M, Kerr KG. Microbiological and clinical aspects of infection associated with Stenotrophomonas maltophilia. Clin Microbiol Rev 1998; 11:57.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/60/8135/abstract/5\">",
"      Calza L, Manfredi R, Chiodo F. Stenotrophomonas (Xanthomonas) maltophilia as an emerging opportunistic pathogen in association with HIV infection: a 10-year surveillance study. Infection 2003; 31:155.",
"     </a>",
"    </li>",
"    <li>",
"     Giligan P, Lum G, Vandamme PAR, Whittier S. Burkholderia, Stenotrophomonas, Ralstonia, Brevundimonas, Comamonas, Delftia, Pandoraea, and Acidovorax. In: Manual of Clinical Microbiology, 8th, Murray PR (Ed), ASM, Washington 2003.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/60/8135/abstract/7\">",
"      Looney WJ, Narita M, M&uuml;hlemann K. Stenotrophomonas maltophilia: an emerging opportunist human pathogen. Lancet Infect Dis 2009; 9:312.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/60/8135/abstract/8\">",
"      Crossman LC, Gould VC, Dow JM, et al. The complete genome, comparative and functional analysis of Stenotrophomonas maltophilia reveals an organism heavily shielded by drug resistance determinants. Genome Biol 2008; 9:R74.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/60/8135/abstract/9\">",
"      Elsner HA, D&uuml;hrsen U, Hollwitz B, et al. Fatal pulmonary hemorrhage in patients with acute leukemia and fulminant pneumonia caused by Stenotrophomonas maltophilia. Ann Hematol 1997; 74:155.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/60/8135/abstract/10\">",
"      Ganadu M, Mura GL, Campus AM, et al. Relapsing pyrogenic reactions due to Xanthomonas maltophilia in a dialysis patient with a long-term central venous catheter. Nephrol Dial Transplant 1996; 11:197.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/60/8135/abstract/11\">",
"      Girijaratnakumari T, Raja A, Ramani R, et al. Meningitis due to Xanthomonas maltophilia. J Postgrad Med 1993; 39:153.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/60/8135/abstract/12\">",
"      Lo WT, Wang CC, Lee CM, Chu ML. Successful treatment of multi-resistant Stenotrophomonas maltophilia meningitis with ciprofloxacin in a pre-term infant. Eur J Pediatr 2002; 161:680.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/60/8135/abstract/13\">",
"      Papadakis KA, Vartivarian SE, Vassilaki ME, Anaissie EJ. Stenotrophomonas maltophilia: an unusual cause of biliary sepsis. Clin Infect Dis 1995; 21:1032.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/60/8135/abstract/14\">",
"      Papadakis KA, Vartivarian SE, Vassilaki ME, Anaissie EJ. Septic prepatellar bursitis caused by Stenotrophomonas (Xanthomonas) maltophilia. Clin Infect Dis 1996; 22:388.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/60/8135/abstract/15\">",
"      Smeets JG, L&ouml;we SH, Veraart JC. Cutaneous infections with Stenotrophomonas maltophilia in patients using immunosuppressive medication. J Eur Acad Dermatol Venereol 2007; 21:1298.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/60/8135/abstract/16\">",
"      Gilardi GL. Infrequently encountered Pseudomonas species causing infection in humans. Ann Intern Med 1972; 77:211.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/60/8135/abstract/17\">",
"      Khardori N, Elting L, Wong E, et al. Nosocomial infections due to Xanthomonas maltophilia (Pseudomonas maltophilia) in patients with cancer. Rev Infect Dis 1990; 12:997.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/60/8135/abstract/18\">",
"      Nicodemo AC, Paez JI. Antimicrobial therapy for Stenotrophomonas maltophilia infections. Eur J Clin Microbiol Infect Dis 2007; 26:229.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/60/8135/abstract/19\">",
"      Gilardi GL. Pseudomonas maltophilia infections in man. Am J Clin Pathol 1969; 51:58.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/60/8135/abstract/20\">",
"      Elting LS, Khardori N, Bodey GP, Fainstein V. Nosocomial infection caused by Xanthomonas maltophilia: a case-control study of predisposing factors. Infect Control Hosp Epidemiol 1990; 11:134.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/60/8135/abstract/21\">",
"      Falagas ME, Kastoris AC, Vouloumanou EK, et al. Attributable mortality of Stenotrophomonas maltophilia infections: a systematic review of the literature. Future Microbiol 2009; 4:1103.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/60/8135/abstract/22\">",
"      Bottone EJ, Reitano M, Janda JM, et al. Pseudomonas maltophilia exoenzyme activity as correlate in pathogenesis of ecthyma gangrenosum. J Clin Microbiol 1986; 24:995.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/60/8135/abstract/23\">",
"      Jucker BA, Harms H, Zehnder AJ. Adhesion of the positively charged bacterium Stenotrophomonas (Xanthomonas) maltophilia 70401 to glass and Teflon. J Bacteriol 1996; 178:5472.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/60/8135/abstract/24\">",
"      de Oliveira-Garcia D, Dall'Agnol M, Rosales M, et al. Fimbriae and adherence of Stenotrophomonas maltophilia to epithelial cells and to abiotic surfaces. Cell Microbiol 2003; 5:625.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/60/8135/abstract/25\">",
"      Di Bonaventura G, Spedicato I, D'Antonio D, et al. Biofilm formation by Stenotrophomonas maltophilia: modulation by quinolones, trimethoprim-sulfamethoxazole, and ceftazidime. Antimicrob Agents Chemother 2004; 48:151.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/60/8135/abstract/26\">",
"      Mart&iacute;nez JL, Baquero F. Interactions among strategies associated with bacterial infection: pathogenicity, epidemicity, and antibiotic resistance. Clin Microbiol Rev 2002; 15:647.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/60/8135/abstract/27\">",
"      de Oliveira-Garcia D, Dall'Agnol M, Rosales M, et al. Characterization of flagella produced by clinical strains of Stenotrophomonas maltophilia. Emerg Infect Dis 2002; 8:918.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/60/8135/abstract/28\">",
"      Waters VJ, G&oacute;mez MI, Soong G, et al. Immunostimulatory properties of the emerging pathogen Stenotrophomonas maltophilia. Infect Immun 2007; 75:1698.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/60/8135/abstract/29\">",
"      Avison MB, Higgins CS, von Heldreich CJ, et al. Plasmid location and molecular heterogeneity of the L1 and L2 beta-lactamase genes of Stenotrophomonas maltophilia. Antimicrob Agents Chemother 2001; 45:413.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/60/8135/abstract/30\">",
"      Crowder MW, Walsh TR, Banovic L, et al. Overexpression, purification, and characterization of the cloned metallo-beta-lactamase L1 from Stenotrophomonas maltophilia. Antimicrob Agents Chemother 1998; 42:921.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/60/8135/abstract/31\">",
"      Saino Y, Inoue M, Mitsuhashi S. Purification and properties of an inducible cephalosporinase from Pseudomonas maltophilia GN12873. Antimicrob Agents Chemother 1984; 25:362.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/60/8135/abstract/32\">",
"      Walsh TR, MacGowan AP, Bennett PM. Sequence analysis and enzyme kinetics of the L2 serine beta-lactamase from Stenotrophomonas maltophilia. Antimicrob Agents Chemother 1997; 41:1460.",
"     </a>",
"    </li>",
"    <li>",
"     Falagas ME, Valkimadi PE, Huang YT, et al. Therapeutic options for Stenotrophomonas maltophilia infections beyond co-trimoxazole: a systemic review. JAC 2008; 62:889.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/60/8135/abstract/34\">",
"      Spencer RC. The emergence of epidemic, multiple-antibiotic-resistant Stenotrophomonas (Xanthomonas) maltophilia and Burkholderia (Pseudomonas) cepacia. J Hosp Infect 1995; 30 Suppl:453.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/60/8135/abstract/35\">",
"      Hancock RE. Resistance mechanisms in Pseudomonas aeruginosa and other nonfermentative gram-negative bacteria. Clin Infect Dis 1998; 27 Suppl 1:S93.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/60/8135/abstract/36\">",
"      Lambert T, Ploy MC, Denis F, Courvalin P. Characterization of the chromosomal aac(6')-Iz gene of Stenotrophomonas maltophilia. Antimicrob Agents Chemother 1999; 43:2366.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/60/8135/abstract/37\">",
"      Li XZ, Zhang L, McKay GA, Poole K. Role of the acetyltransferase AAC(6')-Iz modifying enzyme in aminoglycoside resistance in Stenotrophomonas maltophilia. J Antimicrob Chemother 2003; 51:803.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/60/8135/abstract/38\">",
"      Poole K. Outer membranes and efflux: the path to multidrug resistance in Gram-negative bacteria. Curr Pharm Biotechnol 2002; 3:77.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/60/8135/abstract/39\">",
"      Safdar A, Rolston KV. Stenotrophomonas maltophilia: changing spectrum of a serious bacterial pathogen in patients with cancer. Clin Infect Dis 2007; 45:1602.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/60/8135/abstract/40\">",
"      Wheat PF, Winstanley TG, Spencer RC. Effect of temperature on antimicrobial susceptibilities of Pseudomonas maltophilia. J Clin Pathol 1985; 38:1055.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/60/8135/abstract/41\">",
"      Rahmati-Bahram A, Magee JT, Jackson SK. Growth temperature-dependent variation of cell envelope lipids and antibiotic susceptibility in Stenotrophomonas (Xanthomonas) maltophilia. J Antimicrob Chemother 1995; 36:317.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/60/8135/abstract/42\">",
"      Rahmati-Bahram A, Magee JT, Jackson SK. Temperature-dependent aminoglycoside resistance in Stenotrophomonas (Xanthomonas) maltophilia; alterations in protein and lipopolysaccharide with growth temperature. J Antimicrob Chemother 1996; 37:665.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/60/8135/abstract/43\">",
"      Rahmati-Bahram A, Magee JT, Jackson SK. Effect of temperature on aminoglycoside binding sites in Stenotrophomonas maltophilia. J Antimicrob Chemother 1997; 39:19.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/60/8135/abstract/44\">",
"      Alonso A, Mart&iacute;nez JL. Cloning and characterization of SmeDEF, a novel multidrug efflux pump from Stenotrophomonas maltophilia. Antimicrob Agents Chemother 2000; 44:3079.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/60/8135/abstract/45\">",
"      Alonso A, Martinez JL. Expression of multidrug efflux pump SmeDEF by clinical isolates of Stenotrophomonas maltophilia. Antimicrob Agents Chemother 2001; 45:1879.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/60/8135/abstract/46\">",
"      Zhang L, Li XZ, Poole K. Fluoroquinolone susceptibilities of efflux-mediated multidrug-resistant Pseudomonas aeruginosa, Stenotrophomonas maltophilia and Burkholderia cepacia. J Antimicrob Chemother 2001; 48:549.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/60/8135/abstract/47\">",
"      Alonso A, Sanchez P, Mart&iacute;nez JL. Stenotrophomonas maltophilia D457R contains a cluster of genes from gram-positive bacteria involved in antibiotic and heavy metal resistance. Antimicrob Agents Chemother 2000; 44:1778.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/60/8135/abstract/48\">",
"      Muder RR, Harris AP, Muller S, et al. Bacteremia due to Stenotrophomonas (Xanthomonas) maltophilia: a prospective, multicenter study of 91 episodes. Clin Infect Dis 1996; 22:508.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/60/8135/abstract/49\">",
"      del Toro MD, Rodr&iacute;guez-Bano J, Herrero M, et al. Clinical epidemiology of Stenotrophomonas maltophilia colonization and infection: a multicenter study. Medicine (Baltimore) 2002; 81:228.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/60/8135/abstract/50\">",
"      Carmeli Y, Samore MH. Comparison of treatment with imipenem vs. ceftazidime as a predisposing factor for nosocomial acquisition of Stenotrophomonas maltophilia: a historical cohort study. Clin Infect Dis 1997; 24:1131.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/60/8135/abstract/51\">",
"      Paez JI, Costa SF. Risk factors associated with mortality of infections caused by Stenotrophomonas maltophilia: a systematic review. J Hosp Infect 2008; 70:101.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/60/8135/abstract/52\">",
"      Morrison AJ Jr, Hoffmann KK, Wenzel RP. Associated mortality and clinical characteristics of nosocomial Pseudomonas maltophilia in a university hospital. J Clin Microbiol 1986; 24:52.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/60/8135/abstract/53\">",
"      Al-Jasser AM. Stenotrophomonas maltophilia resistant to trimethoprim-sulfamethoxazole: an increasing problem. Ann Clin Microbiol Antimicrob 2006; 5:23.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/60/8135/abstract/54\">",
"      Victor MA, Arpi M, Bruun B, et al. Xanthomonas maltophilia bacteremia in immunocompromised hematological patients. Scand J Infect Dis 1994; 26:163.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/60/8135/abstract/55\">",
"      Barchitta M, Cipresso R, Giaquinta L, et al. Acquisition and spread of Acinetobacter baumannii and Stenotrophomonas maltophilia in intensive care patients. Int J Hyg Environ Health 2009; 212:330.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/60/8135/abstract/56\">",
"      Senol E, DesJardin J, Stark PC, et al. Attributable mortality of Stenotrophomonas maltophilia bacteremia. Clin Infect Dis 2002; 34:1653.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/60/8135/abstract/57\">",
"      Wang WS, Liu CP, Lee CM, Huang FY. Stenotrophomonas maltophilia bacteremia in adults: four years' experience in a medical center in northern Taiwan. J Microbiol Immunol Infect 2004; 37:359.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/60/8135/abstract/58\">",
"      Gales AC, Jones RN, Forward KR, et al. Emerging importance of multidrug-resistant Acinetobacter species and Stenotrophomonas maltophilia as pathogens in seriously ill patients: geographic patterns, epidemiological features, and trends in the SENTRY Antimicrobial Surveillance Program (1997-1999). Clin Infect Dis 2001; 32 Suppl 2:S104.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/60/8135/abstract/59\">",
"      K&ouml;seolu O, Sener B, G&uuml;lmez D, et al. Stenotrophomonas maltophilia as a nosocomial pathogen. New Microbiol 2004; 27:273.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/60/8135/abstract/60\">",
"      Micozzi A, Venditti M, Monaco M, et al. Bacteremia due to Stenotrophomonas maltophilia in patients with hematologic malignancies. Clin Infect Dis 2000; 31:705.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/60/8135/abstract/61\">",
"      Chen YF, Chung PC, Hsiao CH. Stenotrophomonas maltophilia keratitis and scleritis. Chang Gung Med J 2005; 28:142.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/60/8135/abstract/62\">",
"      Penland RL, Wilhelmus KR. Stenotrophomonas maltophilia ocular infections. Arch Ophthalmol 1996; 114:433.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/60/8135/abstract/63\">",
"      Pathmanathan A, Waterer GW. Significance of positive Stenotrophomonas maltophilia culture in acute respiratory tract infection. Eur Respir J 2005; 25:911.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/60/8135/abstract/64\">",
"      Tsiodras S, Pittet D, Carmeli Y, et al. Clinical implications of stenotrophomonas maltophilia resistant to trimethoprim-sulfamethoxazole: a study of 69 patients at 2 university hospitals. Scand J Infect Dis 2000; 32:651.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/60/8135/abstract/65\">",
"      Pankuch GA, Jacobs MR, Rittenhouse SF, Appelbaum PC. Susceptibilities of 123 strains of Xanthomonas maltophilia to eight beta-lactams (including beta-lactam-beta-lactamase inhibitor combinations) and ciprofloxacin tested by five methods. Antimicrob Agents Chemother 1994; 38:2317.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/60/8135/abstract/66\">",
"      Giamarellos-Bourboulis EJ, Karnesis L, Galani I, Giamarellou H. In vitro killing effect of moxifloxacin on clinical isolates of Stenotrophomonas maltophilia resistant to trimethoprim-sulfamethoxazole. Antimicrob Agents Chemother 2002; 46:3997.",
"     </a>",
"    </li>",
"    <li>",
"     Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing: Eighteenth informational supplement [Document M100-S18]. Wayne, PA 2008.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/60/8135/abstract/68\">",
"      Smit WJ, Boquest AL, Geddes JE, Tosolini FA. The antibiotic susceptibilities of Xanthomonas maltophilia and their relation to clinical management. Pathology 1994; 26:321.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/60/8135/abstract/69\">",
"      Vartivarian S, Anaissie E, Bodey G, et al. A changing pattern of susceptibility of Xanthomonas maltophilia to antimicrobial agents: implications for therapy. Antimicrob Agents Chemother 1994; 38:624.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/60/8135/abstract/70\">",
"      Sader HS, Jones RN. Antimicrobial susceptibility of uncommonly isolated non-enteric Gram-negative bacilli. Int J Antimicrob Agents 2005; 25:95.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/60/8135/abstract/71\">",
"      San Gabriel P, Zhou J, Tabibi S, et al. Antimicrobial susceptibility and synergy studies of Stenotrophomonas maltophilia isolates from patients with cystic fibrosis. Antimicrob Agents Chemother 2004; 48:168.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/60/8135/abstract/72\">",
"      Berg G, Roskot N, Smalla K. Genotypic and phenotypic relationships between clinical and environmental isolates of Stenotrophomonas maltophilia. J Clin Microbiol 1999; 37:3594.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/60/8135/abstract/73\">",
"      Maningo E, Watanakunakorn C. Xanthomonas maltophilia and Pseudomonas cepacia in lower respiratory tracts of patients in critical care units. J Infect 1995; 31:89.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/60/8135/abstract/74\">",
"      G&oacute;mez-Garc&eacute;s JL, Aracil B, Gil Y, Burillo A. Susceptibility of 228 non-fermenting gram-negative rods to tigecycline and six other antimicrobial drugs. J Chemother 2009; 21:267.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/60/8135/abstract/75\">",
"      G&uuml;lmez D, Cakar A, Sener B, et al. Comparison of different antimicrobial susceptibility testing methods for Stenotrophomonas maltophilia and results of synergy testing. J Infect Chemother 2010; 16:322.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/60/8135/abstract/76\">",
"      Liaw SJ, Teng LJ, Hsueh PR, et al. In vitro activities of antimicrobial combinations against clinical isolates of Stenotrophomonas maltophilia. J Formos Med Assoc 2002; 101:495.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/60/8135/abstract/77\">",
"      Poulos CD, Matsumura SO, Willey BM, et al. In vitro activities of antimicrobial combinations against Stenotrophomonas (Xanthomonas) maltophilia. Antimicrob Agents Chemother 1995; 39:2220.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 13961 Version 5.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0503-200.131.240.2-C9BE2142DC-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f7_60_8135=[""].join("\n");
var outline_f7_60_8135=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H2964717\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H47084643\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H47084650\">",
"      MICROBIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H47084657\">",
"      EPIDEMIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2963639\">",
"      CLINICAL MANIFESTATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H47084664\">",
"      TREATMENT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2964717\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?19/12/19658?source=related_link\">",
"      General principles of infection control",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f7_60_8136="Evaluation and medical management of giant bullae in COPD";
var content_f7_60_8136=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Evaluation and medical management of giant bullae in COPD",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?7/60/8136/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?7/60/8136/contributors\">",
"     Fernando J Martinez, MD, MS",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?7/60/8136/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?7/60/8136/contributors\">",
"     James K Stoller, MS, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?7/60/8136/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?7/60/8136/contributors\">",
"     Helen Hollingsworth, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?7/60/8136/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   May 11, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;A bulla is defined as an air space in the lung measuring more than one centimeter in diameter in the distended state. The term giant bulla is used for bullae that occupy at least 30 percent of a hemithorax [",
"    <a class=\"abstract\" href=\"UTD.htm?7/60/8136/abstract/1-4\">",
"     1-4",
"    </a>",
"    ]. A single giant bulla may be present, or a giant bulla may be accompanied by a number of smaller adjacent bullae.",
"   </p>",
"   <p>",
"    The evaluation and management of giant bullae in patients with emphysema will be reviewed here. The general management of chronic obstructive pulmonary disease, and the roles of bullectomy, lung volume reduction surgery, and lung transplantation in the management of advanced emphysema are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?38/26/39338?source=see_link\">",
"     \"Management of stable chronic obstructive pulmonary disease\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/57/28568?source=see_link\">",
"     \"Bullectomy for giant bullae in COPD\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/30/33257?source=see_link\">",
"     \"Lung volume reduction surgery in COPD\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/20/26953?source=see_link\">",
"     \"Lung transplantation: General guidelines for recipient selection\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     ETIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Giant bullae typically develop as a consequence of cigarette smoking. Marijuana smoking has been associated with giant bullae in a few patients, although this observation may be confounded by concomitant cigarette smoke exposure [",
"    <a class=\"abstract\" href=\"UTD.htm?7/60/8136/abstract/5\">",
"     5",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Bullous lung disease has also been described in association with HIV infection and in intravenous drug users, particularly following injection of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?35/57/36761?source=see_link\">",
"     methadone",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?38/60/39881?source=see_link\">",
"     methylphenidate",
"    </a>",
"    , or talc-containing drugs, although these relationships are not clearly established. In methylphenidate injectors, the pattern of emphysema is basilar, similar to that seen in patients with alpha-1 antitrypsin deficiency. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/34/38439?source=see_link&amp;anchor=H6#H6\">",
"     \"Overview of pulmonary disease in injection drug users\", section on 'Bullous lung disease and emphysema'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?36/44/37575?source=see_link\">",
"     \"Emphysema-like disease in HIV infection\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Patients with Marfan's syndrome occasionally develop apical bullae, but these generally do not meet criteria for giant bullae. Similarly, bullae have been described in Sj&ouml;gren's syndrome and sarcoidosis, but usually not giant bullae [",
"    <a class=\"abstract\" href=\"UTD.htm?7/60/8136/abstract/6,7\">",
"     6,7",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?20/3/20538?source=see_link\">",
"     \"Genetics, clinical features, and diagnosis of Marfan syndrome and related disorders\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     CLINICAL MANIFESTATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with giant bullae may be asymptomatic, dyspneic on exertion, or dyspneic with rest and exertion [",
"    <a class=\"abstract\" href=\"UTD.htm?7/60/8136/abstract/8\">",
"     8",
"    </a>",
"    ]. Other manifestations of chronic obstructive pulmonary disease (COPD), such as cough and sputum production, may or may not be present. Patients with an infected bulla typically have symptoms and signs of systemic infection, as described below.",
"   </p>",
"   <p>",
"    Physical examination may be normal or may reveal tachypnea, a barrel-shaped chest, hyperresonance on chest percussion, and decreased breath sounds. Findings may be unilateral or bilateral.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     EVALUATION AND DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Giant bullae are often detected when a chest radiograph is performed to evaluate dyspnea or symptoms of a respiratory infection. Further evaluation generally includes assessment of alpha-1 antitrypsin serum levels, pulmonary function tests, gas exchange, and computed tomography.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Laboratory testing",
"    </span>",
"    &nbsp;&mdash;&nbsp;Routine laboratory testing in the evaluation of giant bullae typically includes the measurement of hemoglobin and hematocrit, an alpha-1 antitrypsin level, and arterial blood gases, performed while the patient is breathing room air, if possible.",
"   </p>",
"   <p>",
"    The hemoglobin concentration is assessed to exclude anemia as a contributor to dyspnea and to evaluate for secondary polycythemia due to chronic hypoxemia. Polycythemia is suggested by hemoglobin concentrations of 16.5 or 18.5",
"    <span class=\"nowrap\">",
"     g/dL",
"    </span>",
"    in women or men, respectively. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/12/24777?source=see_link&amp;anchor=H23#H23\">",
"     \"Diagnostic approach to the patient with polycythemia\", section on 'Acquired secondary polycythemia'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The diagnosis of severe AAT deficiency is made by demonstrating a serum level of alpha-1 antitrypsin below 11",
"    <span class=\"nowrap\">",
"     &micro;mol/L",
"    </span>",
"    (corresponding to 80",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    in some assays and 50",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    by nephelometry) in combination with confirmation of a severely deficient genotype, generally determined by isoelectric focusing. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?6/8/6281?source=see_link\">",
"     \"Clinical manifestations, diagnosis, and natural history of alpha-1 antitrypsin deficiency\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Arterial blood gases are usually only necessary in patients with severe respiratory impairment and those who are being considered for bullectomy. The arterial partial pressure of oxygen (PaO2) is usually reduced and the arterial partial pressure of carbon dioxide (PaCO2) is normal or mildly increased [",
"    <a class=\"abstract\" href=\"UTD.htm?7/60/8136/abstract/9,10\">",
"     9,10",
"    </a>",
"    ]. A PaCO2 greater than 45 mmHg is considered a relative contraindication for bullectomy (",
"    <a class=\"graphic graphic_table graphicRef68646 \" href=\"UTD.htm?28/38/29292\">",
"     table 1",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?7/60/8136/abstract/11,12\">",
"     11,12",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/57/28568?source=see_link&amp;anchor=H5#H5\">",
"     \"Bullectomy for giant bullae in COPD\", section on 'Contraindications'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Pulmonary function tests",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pulmonary function tests (PFTs) are indicated in all patients with a giant bulla to assess airflow limitation and air trapping. This information is used to guide medical therapy for COPD and recommendations regarding possible bullectomy (",
"    <a class=\"graphic graphic_table graphicRef68646 \" href=\"UTD.htm?28/38/29292\">",
"     table 1",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?38/26/39338?source=see_link\">",
"     \"Management of stable chronic obstructive pulmonary disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The typical PFT values for patients who undergo bullectomy cover a broad range. In case series of patients who underwent bullectomy, moderate to severe airflow limitation and air trapping were reported [",
"    <a class=\"abstract\" href=\"UTD.htm?7/60/8136/abstract/2,3,13,14\">",
"     2,3,13,14",
"    </a>",
"    ]. The mean forced expiratory volume in one second (FEV1) ranged from 32 to 64 percent predicted,",
"    <span class=\"nowrap\">",
"     FEV1/forced",
"    </span>",
"    vital capacity (FVC) ratio 37 to 53 percent, total lung capacity (TLC) 110 to 131 percent of predicted, and residual volume (RV) 226 to 268 percent predicted. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/57/28568?source=see_link&amp;anchor=H4#H4\">",
"     \"Bullectomy for giant bullae in COPD\", section on 'Indications'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The difference in lung volume measurements obtained by the body plethysmography and helium dilution techniques can be compared to estimate the volume of nonventilated lung. A larger nonventilated volume suggests that the patient is likely to derive a greater benefit from bullectomy. Chest computed tomography (CT) scanning provides a direct visual assessment of the extent to which normal lung is compressed by bullae and complements the physiologic measures by indicating the integrity of the remaining unaffected lung. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?4/53/4952?source=see_link&amp;anchor=H6#H6\">",
"     \"Overview of pulmonary function testing in adults\", section on 'Lung volumes'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Gas transfer is assessed with a diffusing capacity for carbon monoxide (DLCO) and pulse oximetry. In case series of patients who underwent bullectomy, the baseline DLCO ranged from 57 to 70 percent predicted [",
"    <a class=\"abstract\" href=\"UTD.htm?7/60/8136/abstract/2,3,13\">",
"     2,3,13",
"    </a>",
"    ]. In general, the lower the DLCO, the greater the likelihood that the patient has diffuse underlying emphysema, which increases the risk of bullectomy [",
"    <a class=\"abstract\" href=\"UTD.htm?7/60/8136/abstract/12\">",
"     12",
"    </a>",
"    ]. Emphysematous changes in the lung surrounding the giant bulla make the lung more fragile and increase the likelihood of air leaks and diffuse emphysema increases general perioperative risks. Thus, a DLCO less than 40 percent predicted is considered a contraindication to bullectomy [",
"    <a class=\"abstract\" href=\"UTD.htm?7/60/8136/abstract/12\">",
"     12",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?7/14/7400?source=see_link\">",
"     \"Diffusing capacity for carbon monoxide\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/57/28568?source=see_link&amp;anchor=H5#H5\">",
"     \"Bullectomy for giant bullae in COPD\", section on 'Contraindications'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Oxygenation is usually assessed by pulse oximetry at rest and during a six-minute walk to quantify the gas exchange abnormality and guide oxygen supplementation. Parameters of oxygenation and exercise tolerance to guide management decisions regarding bullectomy are lacking. In an observational series of patients who underwent bullectomy, the six-minute walk distance was 311 m at baseline, 375 m after pulmonary rehabilitation, and 424 m six months after bullectomy [",
"    <a class=\"abstract\" href=\"UTD.htm?7/60/8136/abstract/13\">",
"     13",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/30/33257?source=see_link&amp;anchor=H9#H9\">",
"     \"Lung volume reduction surgery in COPD\", section on 'Indications'",
"    </a>",
"    .) A cardiopulmonary exercise test may be useful, especially as part of longitudinal assessments for progression, to indicate the degree of impairment capacity, as well as unmask unrecognized cardiac abnormalities. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/39/33398?source=see_link\">",
"     \"Functional exercise testing: Ventilatory gas analysis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Imaging",
"    </span>",
"    &nbsp;&mdash;&nbsp;Giant bullae are typically visible on a plain chest radiograph (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef82207 \" href=\"UTD.htm?20/54/21349\">",
"     image 1",
"    </a>",
"    ), although they may be mistaken for a pneumothorax and the extent of underlying emphysema may not be apparent. Thus, chest computed tomographic (CT) scanning is typically obtained to confirm the presence of giant bullae, examine the adjacent lung tissue, and rule out a pneumothorax (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef76182 \" href=\"UTD.htm?38/47/39665\">",
"     image 2",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?7/60/8136/abstract/15\">",
"     15",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    On plain chest radiographs, the characteristics of the pleural line help to differentiate a giant, thin-walled bulla from a pneumothorax. In general, the pleural line associated with a large bulla is usually concave (open angle) relative to the lateral chest wall, whereas the pleural line associated with a pneumothorax is convex (narrow angle) relative to the lateral chest wall (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef82207 \" href=\"UTD.htm?20/54/21349\">",
"     image 1",
"    </a>",
"    and",
"    <a class=\"graphic graphic_diagnosticimage graphicRef56589 \" href=\"UTD.htm?40/52/41797\">",
"     image 3",
"    </a>",
"    ). However, the two conditions are more easily differentiated by computed tomography of the chest. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/19/22838?source=see_link&amp;anchor=H11#H11\">",
"     \"Imaging of pneumothorax\", section on 'Conditions mimicking pneumothorax'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?23/35/24121?source=see_link&amp;anchor=H8#H8\">",
"     \"Secondary spontaneous pneumothorax in adults\", section on 'Imaging and diagnosis'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    On chest CT scanning, giant bullae are predominantly located in the upper lobes and are generally subpleural [",
"    <a class=\"abstract\" href=\"UTD.htm?7/60/8136/abstract/15,16\">",
"     15,16",
"    </a>",
"    ]. However, in patients with alpha-1 antitrypsin deficiency, the bullae are most commonly located at the lung bases (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef64765 \" href=\"UTD.htm?1/42/1697\">",
"     image 4",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?6/8/6281?source=see_link\">",
"     \"Clinical manifestations, diagnosis, and natural history of alpha-1 antitrypsin deficiency\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    About half of the patients have bilateral bullae and half will have predominantly unilateral disease. In the area of lung adjacent to the giant bulla, bronchovascular markings are usually compressed [",
"    <a class=\"abstract\" href=\"UTD.htm?7/60/8136/abstract/15\">",
"     15",
"    </a>",
"    ]. Occasionally, deviation of the mediastinal structures to the contralateral side may be noted (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef76182 \" href=\"UTD.htm?38/47/39665\">",
"     image 2",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?7/60/8136/abstract/17\">",
"     17",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The wall thickness of giant bullae is approximately 1 mm. When the wall is thicker, other possibilities should be considered, such as cavitary mycobacterial or fungal infection, cavitating granulomas, and bronchogenic carcinoma. Bronchogenic carcinoma can arise in the wall of the bulla, causing focal thickening or nodularity, or can present as a cavitating mass with central necrosis. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?16/43/17080?source=see_link&amp;anchor=H9#H9\">",
"     \"Computed tomographic and positron emission tomographic scanning of pulmonary nodules\", section on 'Morphology'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Bronchoscopy",
"    </span>",
"    &nbsp;&mdash;&nbsp;In general, flexible fiberoptic bronchoscopy is not useful in the routine evaluation of giant bullae. In a study that assessed the role of bronchoscopy in 52 patients with fluid-filled bullae, bronchoscopy was performed in two-thirds and was noncontributory in all cases [",
"    <a class=\"abstract\" href=\"UTD.htm?7/60/8136/abstract/18\">",
"     18",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h1\">",
"     MANAGEMENT",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Asymptomatic patients",
"    </span>",
"    &nbsp;&mdash;&nbsp;For asymptomatic giant bullae, the key intervention is smoking cessation to prevent further progression of COPD [",
"    <a class=\"abstract\" href=\"UTD.htm?7/60/8136/abstract/19\">",
"     19",
"    </a>",
"    ]. Additional medical and surgical therapy is usually deferred pending development of symptoms or other complications. Periodic reassessment of symptoms, pulmonary function tests, exercise tests, and chest radiograph is appropriate, as the natural history of giant bullae is characterized by progressive enlargement and increasing dyspnea [",
"    <a class=\"abstract\" href=\"UTD.htm?7/60/8136/abstract/16\">",
"     16",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Symptomatic patients",
"    </span>",
"    &nbsp;&mdash;&nbsp;For patients who have symptomatic obstructive airways disease after smoking cessation, the next step is optimization of medical therapy and supportive care (eg, bronchodilators, inhaled glucocorticoids, vaccinations, supplemental oxygen, pulmonary rehabilitation) for COPD, which is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?38/26/39338?source=see_link\">",
"     \"Management of stable chronic obstructive pulmonary disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h3\">",
"     Bullectomy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Bullectomy involves the surgical removal of one or more giant bullae by thoracotomy or video-assisted thoracoscopic surgery. For patients whose dyspnea and exercise intolerance persist despite optimization of medical therapy and pulmonary rehabilitation, bullectomy may be beneficial [",
"    <a class=\"abstract\" href=\"UTD.htm?7/60/8136/abstract/2,3,13,19-24\">",
"     2,3,13,19-24",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/57/28568?source=see_link&amp;anchor=H3#H3\">",
"     \"Bullectomy for giant bullae in COPD\", section on 'Potential benefits'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Some clinicians also advise bullectomy when a bulla is larger than 50 percent of the hemithorax even when symptoms are minimal, because of the risk of spontaneous pneumothorax. However, prospective data to support this practice is lacking.",
"   </p>",
"   <p>",
"    The indications, contraindications, technique, and outcomes of bullectomy are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/57/28568?source=see_link\">",
"     \"Bullectomy for giant bullae in COPD\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h1\">",
"     COMPLICATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The clinical course of giant bullae may be complicated by pneumothorax, bronchogenic carcinoma, or fluid accumulation within the bulla. The exact incidence of these complications is not known.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Pneumothorax",
"    </span>",
"    &nbsp;&mdash;&nbsp;Secondary spontaneous pneumothorax is a well-described complication of giant bullae. The typical presentation is a sudden onset or worsening of dyspnea with or without pleuritic chest pain. When a pneumothorax is suspected, chest computed tomography (CT) scan is key to differentiating a giant bulla from a pneumothorax. (See",
"    <a class=\"local\" href=\"#H7\">",
"     'Imaging'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    A few case reports have described a pneumothorax occurring when a bronchogenic carcinoma eroded through the wall of a bulla [",
"    <a class=\"abstract\" href=\"UTD.htm?7/60/8136/abstract/25\">",
"     25",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H15\">",
"     'Bronchogenic carcinoma'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    All patients with a secondary spontaneous pneumothorax (SSP) should be hospitalized because the diminished pulmonary reserve due to underlying lung disease increases the risk of an adverse outcome (eg, persistent air leak, hypoxemia, respiratory failure). Tube thoracostomy drainage of pleural air is often needed, depending on the size of the pneumothorax and the degree of respiratory impairment.",
"   </p>",
"   <p>",
"    Subsequent management is directed at preventing recurrence. For patients with a giant bulla and a secondary spontaneous pneumothorax, we recommend pleurodesis using mechanical abrasion of the pleura via video-assisted thoracoscopic surgery (VATS). For patients with minimal surrounding diffuse emphysema, a bullectomy is typically performed at the time of pleurodesis. However, for patients with diffuse bullous emphysema, pleurodesis is often performed without bullectomy.",
"   </p>",
"   <p>",
"    Data supporting these choices is lacking. The management of secondary spontaneous pneumothorax is discussed in more detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?23/35/24121?source=see_link&amp;anchor=H9#H9\">",
"     \"Secondary spontaneous pneumothorax in adults\", section on 'Treatment'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Bronchogenic carcinoma",
"    </span>",
"    &nbsp;&mdash;&nbsp;A number of case reports and case series have described bronchogenic carcinoma arising within or adjacent to giant bullae [",
"    <a class=\"abstract\" href=\"UTD.htm?7/60/8136/abstract/25-29\">",
"     25-29",
"    </a>",
"    ]. Presenting manifestations include pneumothorax and hemoptysis. However, the carcinoma is sometimes identified incidentally at the time of surgery for resection of a giant bulla [",
"    <a class=\"abstract\" href=\"UTD.htm?7/60/8136/abstract/28\">",
"     28",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Several different computed tomography (CT) appearances have been reported for bronchogenic carcinoma associated with giant bullae, including a nodule or mass extruding from the wall of the bulla, a nodule or mass confined within the lumen, a soft-tissue density thickening the wall of the bulla, a pneumothorax, and an air-fluid level [",
"    <a class=\"abstract\" href=\"UTD.htm?7/60/8136/abstract/26,29\">",
"     26,29",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    For patients with these CT findings, tissue examination is generally required for diagnosis. However, studies such as positron emission tomography (PET), alone or integrated with computed tomography (CT), are usually performed to assess the likelihood that a nodule is malignant and the radiographic extent of disease. Flexible fiberoptic bronchoscopy is typically performed preoperatively or intraoperatively to stage the airway. Brushings, washings, and endobronchial biopsy obtained during preoperative bronchoscopy have a low yield when bronchogenic carcinoma is the cause of a small peripheral or intrabulla nodule. Patients with severe dyspnea due to the bulla and underlying COPD will need an assessment of whether",
"    <span class=\"nowrap\">",
"     bullectomy/lobectomy",
"    </span>",
"    will improve their respiratory function adequately for them to tolerate resectional surgery. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?12/61/13273?source=see_link\">",
"     \"Overview of the initial evaluation, treatment and prognosis of lung cancer\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?43/31/44537?source=see_link&amp;anchor=H15#H15\">",
"     \"Diagnostic evaluation and management of the solitary pulmonary nodule\", section on 'Bronchoscopy'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/57/28568?source=see_link\">",
"     \"Bullectomy for giant bullae in COPD\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Fluid-containing bullae",
"    </span>",
"    &nbsp;&mdash;&nbsp;The etiology of fluid-containing bullae includes an inflammatory, sterile reaction to an adjacent pneumonia, infection within the bulla, malignancy, and unknown benign causes [",
"    <a class=\"abstract\" href=\"UTD.htm?7/60/8136/abstract/18,29-32\">",
"     18,29-32",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h3\">",
"     Imaging",
"    </span>",
"    &nbsp;&mdash;&nbsp;The determination that the air-fluid level is in a bulla and not in a newly formed cyst or cavity is based on the new appearance of fluid in a previously identified bulla or the presence of other bullae in a patient with known COPD [",
"    <a class=\"abstract\" href=\"UTD.htm?7/60/8136/abstract/18\">",
"     18",
"    </a>",
"    ]. Computed tomography (CT) of the chest is indicated to confirm that the air-fluid level is in a bulla and to identify any surrounding pneumonitis, adjacent pulmonary nodule, or increase in wall thickness of the bulla.",
"   </p>",
"   <p>",
"    In addition, the thickness of the bulla wall on chest CT helps to differentiate an air-fluid level within a bulla from diseases such as tuberculosis, fungal disease, lung abscess, or cavitary bronchogenic lung cancer. The latter processes typically have substantially thicker cavity walls, than the 1 mm thickness typical of bullae. However, bronchogenic carcinoma can rarely arise in the wall of a giant bulla, as described above, so a narrower wall thickness does not entirely exclude the possibility of carcinoma [",
"    <a class=\"abstract\" href=\"UTD.htm?7/60/8136/abstract/28,29\">",
"     28,29",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    CT scanning also assesses the presence and extent of any surrounding pneumonitis or nodular quality to the bulla wall [",
"    <a class=\"abstract\" href=\"UTD.htm?7/60/8136/abstract/18\">",
"     18",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h3\">",
"     Benign, sterile bullous fluid",
"    </span>",
"    &nbsp;&mdash;&nbsp;Benign, sterile fluid accumulations are thought to result from pneumonia in the adjacent lung parenchyma (analogous to a parapneumonic pleural effusion) or from poorly functioning bronchial communications with inadequate drainage of normally accumulating fluid.",
"   </p>",
"   <p>",
"    For patients who are asymptomatic and have a thin-walled bulla without chest CT evidence of an adjacent pneumonitis or nodule, continued observation without specific therapy is usually indicated [",
"    <a class=\"abstract\" href=\"UTD.htm?7/60/8136/abstract/18,30\">",
"     18,30",
"    </a>",
"    ]. Repeat evaluation and chest CT scan are typically performed at six to twelve week intervals to ensure that an infection or bronchogenic carcinoma is not being overlooked [",
"    <a class=\"abstract\" href=\"UTD.htm?7/60/8136/abstract/29\">",
"     29",
"    </a>",
"    ]. Resolution of benign, sterile accumulations may take 10 to 270 days [",
"    <a class=\"abstract\" href=\"UTD.htm?7/60/8136/abstract/29,30\">",
"     29,30",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H15\">",
"     'Bronchogenic carcinoma'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    For patients with clinical and radiographic evidence of adjacent pneumonia (eg, fever, purulent sputum, leukocytosis, radiographic opacity), antibiotic therapy is indicated. The choice of antibiotic and the duration of therapy follow guidelines for community-acquired pneumonia in a patient with COPD. The air-fluid level may persist for weeks to months after resolution of other clinical evidence of active infection [",
"    <a class=\"abstract\" href=\"UTD.htm?7/60/8136/abstract/18\">",
"     18",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/24/24969?source=see_link&amp;anchor=H13#H13\">",
"     \"Treatment of community-acquired pneumonia in adults in the outpatient setting\", section on 'Comorbidities or recent antibiotic use'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h3\">",
"     Infected bullae",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with giant bullae occasionally develop superimposed infection within a bulla [",
"    <a class=\"abstract\" href=\"UTD.htm?7/60/8136/abstract/18\">",
"     18",
"    </a>",
"    ]. Clinical manifestations may include fever, cough, purulent sputum production, dyspnea, and pleuritic chest pain. Laboratory findings may include leukocytosis and positive sputum cultures.",
"   </p>",
"   <p>",
"    When clinical and radiographic findings suggest that a bulla is infected, empiric antibiotics are initiated. The initial choice of antibiotics follows that for community-acquired pneumonia in a patient with COPD. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/24/24969?source=see_link&amp;anchor=H13#H13\">",
"     \"Treatment of community-acquired pneumonia in adults in the outpatient setting\", section on 'Comorbidities or recent antibiotic use'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    If a patient fails to improve with empiric antibiotics, percutaneous aspiration of bullous fluid is often performed under CT guidance to confirm the presence of infection and to identify the antibiotic sensitivities of the infecting organism [",
"    <a class=\"abstract\" href=\"UTD.htm?7/60/8136/abstract/18\">",
"     18",
"    </a>",
"    ]. Percutaneous aspiration carries an increased risk of pneumothorax and empyema if infected bullous fluid spills into the pleural space. However, this risk is lower when the bulla abuts the chest wall.",
"   </p>",
"   <p>",
"    Bacterial species that have been identified from aspiration and culture of bullous fluid include methicillin-resistant Staphylococci (MRSA), Bacteroides, and Pseudomonas aeruginosa [",
"    <a class=\"abstract\" href=\"UTD.htm?7/60/8136/abstract/18,31\">",
"     18,31",
"    </a>",
"    ]. The reported range of infecting organisms provides support for direct culture of bullous fluid [",
"    <a class=\"abstract\" href=\"UTD.htm?7/60/8136/abstract/18\">",
"     18",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Occasionally, after resolution of infection, a giant bulla will collapse on itself and the patient's respiratory function will improve such that spirometry and exercise tolerance are better than prior to the infection [",
"    <a class=\"abstract\" href=\"UTD.htm?7/60/8136/abstract/32\">",
"     32",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A bulla is defined as an air space in the lung measuring more than one centimeter in diameter in the distended state; the term giant bulla is used for bullae that occupy at least 30 percent of a hemithorax. A single giant bulla may be present, or a giant bulla may be accompanied by a number of smaller adjacent bullae. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Giant bullae most commonly develop as a consequence of cigarette smoking. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Etiology'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Giant bullae are often detected when a chest radiograph is performed to evaluate dyspnea or symptoms of a respiratory infection. Further evaluation generally includes assessment of alpha-1 antitrypsin serum levels, pulmonary function tests, gas exchange, and computed tomography. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Evaluation and diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Asymptomatic giant bullae do not require specific therapy, other than smoking cessation. For patients with giant bullae who have symptomatic obstructive airways disease despite smoking cessation, the first step is optimization of medical and supportive therapy for COPD. (See",
"      <a class=\"local\" href=\"#H9\">",
"       'Management'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      For patients with inadequate relief of dyspnea with medical therapy and pulmonary rehabilitation for COPD, resection of a giant bulla (also known as bullectomy) may provide a symptomatic and functional improvement. Surgical aspects of bullectomy are discussed separately. (See",
"      <a class=\"local\" href=\"#H11\">",
"       'Symptomatic patients'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?27/57/28568?source=see_link\">",
"       \"Bullectomy for giant bullae in COPD\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Secondary spontaneous pneumothorax is a well-described complication of giant bullae and requires initial hospitalization. Tube thoracostomy drainage of pleural air is often needed, depending on the size of the pneumothorax and the degree of respiratory impairment. Subsequent management is directed at preventing recurrence. (See",
"      <a class=\"local\" href=\"#H14\">",
"       'Pneumothorax'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      For most patients with a giant bulla and a secondary spontaneous pneumothorax, we recommend video-assisted thoracoscopic surgery (VATS) with pleurodesis, due to the high risk of recurrence (",
"      <a class=\"grade\" href=\"._grade_2?title=Grade 1B\">",
"       Grade 1B",
"      </a>",
"      ). For patients with minimal surrounding diffuse emphysema, a bullectomy is typically performed at the time of pleurodesis. However, for patients with diffuse bullous emphysema, pleurodesis may be performed without bullectomy. (See",
"      <a class=\"local\" href=\"#H14\">",
"       'Pneumothorax'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?23/35/24121?source=see_link\">",
"       \"Secondary spontaneous pneumothorax in adults\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      The high resolution computed tomography (CT) appearance of bronchogenic carcinoma complicating the course of a giant bulla includes a nodule or mass extruding into the lung parenchyma from the wall of the bulla, a nodule or mass confined within the lumen, a soft-tissue density thickening the wall of the bulla, and an air-fluid level. (See",
"      <a class=\"local\" href=\"#H15\">",
"       'Bronchogenic carcinoma'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Occasionally, an air-fluid level develops within a giant bulla due to an inflammatory, sterile reaction to an adjacent pneumonia, an infection within the bulla, a malignancy, or an unknown benign process. (See",
"      <a class=\"local\" href=\"#H16\">",
"       'Fluid-containing bullae'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Initial antibiotic treatment of pneumonia adjacent to a bulla or infection within a bulla follows guidelines for community-acquired pneumonia in a patient with COPD. Rare patients with infection within a bulla require CT guided aspiration to obtain specific culture and sensitivity information. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?24/24/24969?source=see_link&amp;anchor=H13#H13\">",
"       \"Treatment of community-acquired pneumonia in adults in the outpatient setting\", section on 'Comorbidities or recent antibiotic use'",
"      </a>",
"      and",
"      <a class=\"local\" href=\"#H19\">",
"       'Infected bullae'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/60/8136/abstract/1\">",
"      Thurlbeck WM. Pathophysiology of chronic obstructive pulmonary disease. Clin Chest Med 1990; 11:389.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/60/8136/abstract/2\">",
"      Palla A, Desideri M, Rossi G, et al. Elective surgery for giant bullous emphysema: a 5-year clinical and functional follow-up. Chest 2005; 128:2043.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/60/8136/abstract/3\">",
"      Neviere R, Catto M, Bautin N, et al. Longitudinal changes in hyperinflation parameters and exercise capacity after giant bullous emphysema surgery. J Thorac Cardiovasc Surg 2006; 132:1203.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/60/8136/abstract/4\">",
"      Celli BR, MacNee W, ATS/ERS Task Force. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J 2004; 23:932.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/60/8136/abstract/5\">",
"      Johnson MK, Smith RP, Morrison D, et al. Large lung bullae in marijuana smokers. Thorax 2000; 55:340.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/60/8136/abstract/6\">",
"      Inokuma S. Pulmonary involvement in Sj&ouml;gren's syndrome. Intern Med 2002; 41:73.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/60/8136/abstract/7\">",
"      Mireles-Cabodevila E, Sahi H, Farver C, et al. A young patient with a minimal smoking history presents with bullous emphysema and recurrent pneumothorax. Chest 2007; 132:338.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/60/8136/abstract/8\">",
"      Meyers BF, Patterson GA. Chronic obstructive pulmonary disease. 10: Bullectomy, lung volume reduction surgery, and transplantation for patients with chronic obstructive pulmonary disease. Thorax 2003; 58:634.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/60/8136/abstract/9\">",
"      Boushy SF, Kohen R, Billig DM, Heiman MJ. Bullous emphysema: clinical, roentgenologic and physiologic study of 49 patients. Dis Chest 1968; 54:327.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/60/8136/abstract/10\">",
"      Barker SJ, Clarke C, Trivedi N, et al. Anesthesia for thoracoscopic laser ablation of bullous emphysema. Anesthesiology 1993; 78:44.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/60/8136/abstract/11\">",
"      Ohta M, Nakahara K, Yasumitsu T, et al. Prediction of postoperative performance status in patients with giant bulla. Chest 1992; 101:668.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/60/8136/abstract/12\">",
"      Martinez FJ, Chang A. Surgical therapy for chronic obstructive pulmonary disease. Semin Respir Crit Care Med 2005; 26:167.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/60/8136/abstract/13\">",
"      Schipper PH, Meyers BF, Battafarano RJ, et al. Outcomes after resection of giant emphysematous bullae. Ann Thorac Surg 2004; 78:976.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/60/8136/abstract/14\">",
"      Nickoladze GD. Functional results of surgery for bullous emphysema. Chest 1992; 101:119.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/60/8136/abstract/15\">",
"      Sharma N, Justaniah AM, Kanne JP, et al. Vanishing lung syndrome (giant bullous emphysema): CT findings in 7 patients and a literature review. J Thorac Imaging 2009; 24:227.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/60/8136/abstract/16\">",
"      Stern EJ, Webb WR, Weinacker A, M&uuml;ller NL. Idiopathic giant bullous emphysema (vanishing lung syndrome): imaging findings in nine patients. AJR Am J Roentgenol 1994; 162:279.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/60/8136/abstract/17\">",
"      Chen CK, Cheng HK, Chang WH, et al. Giant emphysematous bulla mimicking tension pneumothorax. Am J Med Sci 2009; 337:205.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/60/8136/abstract/18\">",
"      Chandra D, Rose SR, Carter RB, et al. Fluid-containing emphysematous bullae: a spectrum of illness. Eur Respir J 2008; 32:303.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/60/8136/abstract/19\">",
"      Snider GL. Reduction pneumoplasty for giant bullous emphysema. Implications for surgical treatment of nonbullous emphysema. Chest 1996; 109:540.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/60/8136/abstract/20\">",
"      Boasquevisque CH, Yildirim E, Waddel TK, Keshavjee S. Surgical techniques: lung transplant and lung volume reduction. Proc Am Thorac Soc 2009; 6:66.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/60/8136/abstract/21\">",
"      Wakabayashi A, Brenner M, Kayaleh RA, et al. Thoracoscopic carbon dioxide laser treatment of bullous emphysema. Lancet 1991; 337:881.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/60/8136/abstract/22\">",
"      Brenner M, Kayaleh RA, Milne EN, et al. Thoracoscopic laser ablation of pulmonary bullae. Radiographic selection and treatment response. J Thorac Cardiovasc Surg 1994; 107:883.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/60/8136/abstract/23\">",
"      Wakabayashi A. Thoracoscopic technique for management of giant bullous lung disease. Ann Thorac Surg 1993; 56:708.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/60/8136/abstract/24\">",
"      Gaensler EA, Jederlinic PJ, FitzGerald MX. Patient work-up for bullectomy. J Thorac Imaging 1986; 1:75.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/60/8136/abstract/25\">",
"      Hatakeyama S, Tatibana A, Suzuki K, Kobayashi R. [Five cases of lung cancer with emphysematous bullae]. Nihon Kokyuki Gakkai Zasshi 2001; 39:415.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/60/8136/abstract/26\">",
"      Maki D, Takahashi M, Murata K, et al. Computed tomography appearances of bronchogenic carcinoma associated with bullous lung disease. J Comput Assist Tomogr 2006; 30:447.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/60/8136/abstract/27\">",
"      Hirai S, Hamanaka Y, Mitsui N, et al. Primary lung cancer arising from the wall of a giant bulla. Ann Thorac Cardiovasc Surg 2005; 11:109.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/60/8136/abstract/28\">",
"      Arab WA, Echav&eacute; V, Sirois M, Gomes MM. Incidental carcinoma in bullous emphysema. Can J Surg 2009; 52:E56.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/60/8136/abstract/29\">",
"      Richardson MS, Reddy VD, Read CA. New air-fluid levels in bullous lung disease: a reevaluation. J Natl Med Assoc 1996; 88:185.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/60/8136/abstract/30\">",
"      Leatherman JW, McDonald FM, Niewohner DE. Fluid-containing bullae in the lung. South Med J 1985; 78:708.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/60/8136/abstract/31\">",
"      Chandra D, Soubra SH, Musher DM. A 57-year-old man with a fluid-containing lung cavity: infection of an emphysematous bulla with methicillin-resistant Staphylococcus aureus. Chest 2006; 130:1942.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/60/8136/abstract/32\">",
"      Peters JI, Kubitschek KR, Gotlieb MS, Awe RJ. Lung bullae with air-fluid levels. Am J Med 1987; 82:759.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 1462 Version 4.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-60.18.131.125-8B92F8E3C2-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f7_60_8136=[""].join("\n");
var outline_f7_60_8136=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H20\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      ETIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      CLINICAL MANIFESTATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      EVALUATION AND DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Laboratory testing",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Pulmonary function tests",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Imaging",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Bronchoscopy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      MANAGEMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Asymptomatic patients",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Symptomatic patients",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      - Bullectomy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      COMPLICATIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Pneumothorax",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Bronchogenic carcinoma",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Fluid-containing bullae",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      - Imaging",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      - Benign, sterile bullous fluid",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      - Infected bullae",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PULM/1462\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PULM/1462|DiagnosticImage\">",
"      <a href=\"#\" title=\"DIAGNOSTIC IMAGES\">",
"       DIAGNOSTIC IMAGES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?20/54/21349\" title=\"diagnostic image 1\">",
"      Giant bilateral bullae PA",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?38/47/39665\" title=\"diagnostic image 2\">",
"      HRCT giant bulla",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?40/52/41797\" title=\"diagnostic image 3\">",
"      Chest Xray of pneumothorax after stab wound",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?1/42/1697\" title=\"diagnostic image 4\">",
"      Bullae in alpha 1 AT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PULM/1462|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?28/38/29292\" title=\"table 1\">",
"      Selection for bullectomy",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/57/28568?source=related_link\">",
"      Bullectomy for giant bullae in COPD",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?6/8/6281?source=related_link\">",
"      Clinical manifestations, diagnosis, and natural history of alpha-1 antitrypsin deficiency",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?16/43/17080?source=related_link\">",
"      Computed tomographic and positron emission tomographic scanning of pulmonary nodules",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?24/12/24777?source=related_link\">",
"      Diagnostic approach to the patient with polycythemia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?43/31/44537?source=related_link\">",
"      Diagnostic evaluation and management of the solitary pulmonary nodule",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?7/14/7400?source=related_link\">",
"      Diffusing capacity for carbon monoxide",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?36/44/37575?source=related_link\">",
"      Emphysema-like disease in HIV infection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?32/39/33398?source=related_link\">",
"      Functional exercise testing: Ventilatory gas analysis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?20/3/20538?source=related_link\">",
"      Genetics, clinical features, and diagnosis of Marfan syndrome and related disorders",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/19/22838?source=related_link\">",
"      Imaging of pneumothorax",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/20/26953?source=related_link\">",
"      Lung transplantation: General guidelines for recipient selection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?32/30/33257?source=related_link\">",
"      Lung volume reduction surgery in COPD",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?38/26/39338?source=related_link\">",
"      Management of stable chronic obstructive pulmonary disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?37/34/38439?source=related_link\">",
"      Overview of pulmonary disease in injection drug users",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?4/53/4952?source=related_link\">",
"      Overview of pulmonary function testing in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?12/61/13273?source=related_link\">",
"      Overview of the initial evaluation, treatment and prognosis of lung cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?23/35/24121?source=related_link\">",
"      Secondary spontaneous pneumothorax in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?24/24/24969?source=related_link\">",
"      Treatment of community-acquired pneumonia in adults in the outpatient setting",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f7_60_8137="Systemic conditions associated with periodontal disease in children";
var content_f7_60_8137=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Systemic conditions associated with periodontal disease in children",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?7/60/8137/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?7/60/8137/contributors\">",
"     Martha Ann Keels, DDS, PhD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?7/60/8137/contributors\">",
"     Dimitris N Tatakis, DDS, PhD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?7/60/8137/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?7/60/8137/contributors\">",
"     Ann Griffen, DDS, MS",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?7/60/8137/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?7/60/8137/contributors\">",
"     Mary M Torchia, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?7/60/8137/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Dec 10, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Soft tissue lesions of the oral cavity are common in children, and distinguishing between findings that are normal and those that are indicative of gingivitis, periodontal disease, local or systemic infection, and potentially life-threatening systemic conditions is important. The loss of periodontal attachment in children, manifest by tooth mobility or premature loss, can be a symptom of neoplasia, immunodeficiency, or metabolic defects [",
"    <a class=\"abstract\" href=\"UTD.htm?7/60/8137/abstract/1\">",
"     1",
"    </a>",
"    ]. The early detection and treatment of these conditions can be life-saving.",
"   </p>",
"   <p>",
"    Systemic conditions associated with childhood periodontitis will be reviewed here. Soft tissue lesions and periodontitis not associated with systemic conditions are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?29/32/30216?source=see_link\">",
"     \"Soft tissue lesions of the oral cavity in children\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/45/32471?source=see_link\">",
"     \"Overview of gingivitis and periodontitis in children and adolescents\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     HISTIOCYTOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Langerhans cell histiocytosis (previously known as histiocytosis X or eosinophilic granuloma) is a rare disorder that affects infants, children, and young adults and is characterized by histiocytic infiltration of the bones, skin, liver, or other organs [",
"    <a class=\"abstract\" href=\"UTD.htm?7/60/8137/abstract/2\">",
"     2",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?20/53/21338?source=see_link\">",
"     \"Clinical manifestations, pathologic features, and diagnosis of Langerhans cell histiocytosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Langerhans cell histiocytosis (LCH) presents with single or multiple-site involvement. The skin, oral mucosa, bone, and lymph nodes are typical locations for single-site involvement. Multisite involvement occurs in the liver, spleen, lungs, bone marrow, and gastrointestinal and central nervous systems.",
"   </p>",
"   <p>",
"    Between 10 and 20 percent of patients present with infiltration of the oral cavity, usually the posterior mandible [",
"    <a class=\"abstract\" href=\"UTD.htm?7/60/8137/abstract/3\">",
"     3",
"    </a>",
"    ]. The typical dental presentation of LCH is eruption of the primary molars at or soon after birth (",
"    <a class=\"graphic graphic_picture graphicRef70097 \" href=\"UTD.htm?18/31/18942\">",
"     picture 1",
"    </a>",
"    ). Additional oral manifestations include pain; ulceration; enlargement, inflammation, or recession of the gingiva; and mobility of teeth because of expansion of the alveolar bone [",
"    <a class=\"abstract\" href=\"UTD.htm?7/60/8137/abstract/4,5\">",
"     4,5",
"    </a>",
"    ]. Dental radiographs may show discreet, destructive bone lesions that make the teeth appear to be \"floating on air\" [",
"    <a class=\"abstract\" href=\"UTD.htm?7/60/8137/abstract/2,5\">",
"     2,5",
"    </a>",
"    ]. Periosteal new bone formation and slight root resorption also may be present [",
"    <a class=\"abstract\" href=\"UTD.htm?7/60/8137/abstract/6\">",
"     6",
"    </a>",
"    ]. Cases may present as aggressive periodontitis lesions that do not respond to routine periodontal therapy [",
"    <a class=\"abstract\" href=\"UTD.htm?7/60/8137/abstract/7\">",
"     7",
"    </a>",
"    ], despite the presence of periodontal flora typically associated with periodontitis [",
"    <a class=\"abstract\" href=\"UTD.htm?7/60/8137/abstract/8\">",
"     8",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    When periodontal involvement is suspected to be a manifestation of LCH, biopsy of the gingiva or periodontal tissues is needed [",
"    <a class=\"abstract\" href=\"UTD.htm?7/60/8137/abstract/5,7-9\">",
"     5,7-9",
"    </a>",
"    ]. The diagnostic evaluation for children in whom a diagnosis of LCH is being considered is extensive and should be performed in consultation with a pediatric hematologist. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?20/53/21338?source=see_link&amp;anchor=H452648918#H452648918\">",
"     \"Clinical manifestations, pathologic features, and diagnosis of Langerhans cell histiocytosis\", section on 'Diagnosis and differential diagnosis'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The treatment of LCH, discussed in detail separately, can result in the loss or arrested development of teeth. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/45/28378?source=see_link&amp;anchor=H6872370#H6872370\">",
"     \"Treatment of Langerhans cell histiocytosis\", section on 'Adults'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?20/53/21338?source=see_link&amp;anchor=H452648841#H452648841\">",
"     \"Clinical manifestations, pathologic features, and diagnosis of Langerhans cell histiocytosis\", section on 'Lytic bone lesions'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     LEUKEMIA",
"    </span>",
"    &nbsp;&mdash;&nbsp;Leukemia, particularly the monocytic type, can cause gingival enlargement because of infiltration of the gingival tissues [",
"    <a class=\"abstract\" href=\"UTD.htm?7/60/8137/abstract/10\">",
"     10",
"    </a>",
"    ]. Leukemic gingival enlargement is typically painless, shiny, red, and edematous; bleeding is common and can make it difficult to maintain oral hygiene. Necrotic ulceration and involvement of the underlying bone also can occur [",
"    <a class=\"abstract\" href=\"UTD.htm?7/60/8137/abstract/11\">",
"     11",
"    </a>",
"    ]. The inflammation that results may act as a stimulus for further gingival swelling [",
"    <a class=\"abstract\" href=\"UTD.htm?7/60/8137/abstract/12\">",
"     12",
"    </a>",
"    ]. Additional symptoms include fever, malaise, easy bruising or bleeding, and bone or joint pain.",
"   </p>",
"   <p>",
"    The diagnosis of leukemia should be considered in patients who have hemorrhagic gingival edema and anemia, thrombocytopenia, or abnormal leukocyte and differential counts on complete blood count. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?3/58/4009?source=see_link\">",
"     \"Overview of the presentation and classification of acute lymphoblastic leukemia in children\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    As in Langerhans histiocytosis, the treatment of leukemia (both lymphocytic and myelogenous leukemia) can have oral complications, including [",
"    <a class=\"abstract\" href=\"UTD.htm?7/60/8137/abstract/13-15\">",
"     13-15",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Mucositis (",
"      <a class=\"graphic graphic_picture graphicRef79159 \" href=\"UTD.htm?33/41/34462\">",
"       picture 2",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Oral infection with candida, herpes simplex virus, or other opportunistic organisms",
"     </li>",
"     <li>",
"      Gingival inflammation (gingivitis)",
"     </li>",
"     <li>",
"      Spontaneous gingival bleeding (because of thrombocytopenia)",
"     </li>",
"     <li>",
"      Gingival squamous cell carcinoma (as a complication of graft versus host disease in bone marrow transplant recipients)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The chemotherapy-induced oral complications in patients with leukemia are more prevalent immediately after administration of chemotherapy [",
"    <a class=\"abstract\" href=\"UTD.htm?7/60/8137/abstract/16\">",
"     16",
"    </a>",
"    ]. They occur irrespective of the chemotherapy protocol used [",
"    <a class=\"abstract\" href=\"UTD.htm?7/60/8137/abstract/16\">",
"     16",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The oral complications of chemotherapy can be diminished by aggressive preventive care, including comprehensive oral examination before the initiation of cancer therapy [",
"    <a class=\"abstract\" href=\"UTD.htm?7/60/8137/abstract/17-19\">",
"     17-19",
"    </a>",
"    ]. The oral cavity is a reservoir for many microorganisms with the potential to cause systemic infection in the immunocompromised host. In addition, dental plaque causes gingivitis and gingival bleeding. Careful brushing with a soft toothbrush should be continued throughout therapy. Although it has been recommended that toothbrushing be suspended or replaced by cleaning with sponge-tipped brushes (\"toothettes\") when platelet counts are low, these approaches are not adequate for plaque removal, and available evidence suggests problems are more likely to arise when oral hygiene is poor [",
"    <a class=\"abstract\" href=\"UTD.htm?7/60/8137/abstract/15,20\">",
"     15,20",
"    </a>",
"    ]. The prevention and treatment of chemotherapy-related mucositis are discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/22/38250?source=see_link&amp;anchor=H2#H2\">",
"     \"Oral toxicity associated with chemotherapy\", section on 'Mucositis'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     LEUKOCYTE ADHESION DEFICIENCY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Leukocyte adhesion deficiency (LAD) is a recessive genetic disorder characterized by inability of the neutrophils to exit the circulation in response to infection. This migration defect is caused by abnormal leukocyte integrins. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?42/38/43620?source=see_link&amp;anchor=H5#H5\">",
"     \"Primary disorders of phagocytic function: An overview\", section on 'Leukocyte adhesion deficiencies'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Patients with LAD may present with delayed separation of the umbilical cord or recurrent bacterial infections of the ears, sinuses, lungs, and skin. Wounds and abscesses heal poorly, and minimal pus is formed. The number of peripheral neutrophils is increased by their inability to leave the circulation and can be as high as",
"    <span class=\"nowrap\">",
"     100,000/mm3.",
"    </span>",
"    LAD is usually diagnosed on the basis of recurrent infection before oral manifestations occur.",
"   </p>",
"   <p>",
"    Oral manifestations of LAD are seen in the early primary dentition and include severe gingival inflammation, rapid bone loss around nearly all teeth, and mobility and premature loss of teeth. The periodontitis associated with LAD has been called generalized prepubertal periodontitis in the dental literature [",
"    <a class=\"abstract\" href=\"UTD.htm?7/60/8137/abstract/21\">",
"     21",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The diagnosis and treatment of LAD are discussed separately. Meticulous oral hygiene is necessary to control the periodontal disease associated with LAD, but restoration of gingival health may require bone marrow transplantation [",
"    <a class=\"abstract\" href=\"UTD.htm?7/60/8137/abstract/22\">",
"     22",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?42/38/43620?source=see_link&amp;anchor=H5#H5\">",
"     \"Primary disorders of phagocytic function: An overview\", section on 'Leukocyte adhesion deficiencies'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h1\">",
"     NEUTROPENIA",
"    </span>",
"    &nbsp;&mdash;&nbsp;Neutropenia is a hematologic disorder characterized by reduced numbers of circulating neutrophils. It is diagnosed when the absolute neutrophil count (ANC) is less than",
"    <span class=\"nowrap\">",
"     1500/microL.",
"    </span>",
"    (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/47/18170?source=see_link&amp;anchor=H2#H2\">",
"     \"Overview of neutropenia\", section on 'Definitions'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Neutrophils are an important component of the host response to pathogenic dental plaque in the gingival sulcus, and patients with neutropenia are at risk for severe gingivitis and pronounced alveolar bone loss. Periodontal disease occurs in the following types of childhood neutropenia:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Congenital neutropenia",
"     </li>",
"     <li>",
"      Autoimmune neutropenia",
"     </li>",
"     <li>",
"      Cyclic neutropenia",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Congenital",
"    </span>",
"    &nbsp;&mdash;&nbsp;Congenital neutropenia occurs in several conditions where there is a marked decrease in (or lack of) circulating neutrophils from the time of birth. These conditions include infantile agranulocytosis (Kostmann syndrome), Shwachman-Diamond syndrome, myelokathexis, congenital dysgranulopoietic neutropenia, and the Chediak-Higashi syndrome. These are rare disorders, with an estimated frequency of two cases per million population [",
"    <a class=\"abstract\" href=\"UTD.htm?7/60/8137/abstract/23\">",
"     23",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/22/24937?source=see_link\">",
"     \"Congenital neutropenia\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Children with congenital neutropenia are susceptible to recurrent infection, often due to staphylococci and streptococci. Oral lesions, otitis media, respiratory infection, cellulitis, and skin abscesses are the most common. These infections heal slowly and may be fatal. Oral manifestations of congenital neutropenia include ulcers, severe gingivitis, alveolar bone loss, gingival recession, tooth mobility, and premature tooth exfoliation. An observational study suggests that mutations in the elastase gene are particularly significant for the development of periodontal disease in patients with congenital neutropenia [",
"    <a class=\"abstract\" href=\"UTD.htm?7/60/8137/abstract/24\">",
"     24",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The treatment of congenital neutropenia usually involves the administration of",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?43/27/44470?source=see_link\">",
"     granulocyte colony-stimulating factor",
"    </a>",
"    (G-CSF) [",
"    <a class=\"abstract\" href=\"UTD.htm?7/60/8137/abstract/24\">",
"     24",
"    </a>",
"    ] and is discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/22/24937?source=see_link&amp;anchor=H13#H13\">",
"     \"Congenital neutropenia\", section on 'Treatment'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Autoimmune",
"    </span>",
"    &nbsp;&mdash;&nbsp;Autoimmune neutropenia (AIN) is caused by granulocyte-specific antibodies. AIN has been associated with a variety of underlying diseases, including viral infection, collagen vascular disease, primary abnormalities of B or T lymphocytes or natural killer (NK) cells, immune thrombocytopenia (ITP), and autoimmune hemolytic anemia [",
"    <a class=\"abstract\" href=\"UTD.htm?7/60/8137/abstract/25\">",
"     25",
"    </a>",
"    ]. In most cases, however, AIN is not associated with other illness or underlying disease and is referred to as chronic benign neutropenia of infancy and childhood [",
"    <a class=\"abstract\" href=\"UTD.htm?7/60/8137/abstract/26,27\">",
"     26,27",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/33/42520?source=see_link&amp;anchor=H4#H4\">",
"     \"Immune neutropenia\", section on 'Autoimmune neutropenia'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Benign neutropenia of infancy and childhood typically occurs in infants between the ages of 5 to 15 months, but the range extends from one month to adulthood [",
"    <a class=\"abstract\" href=\"UTD.htm?7/60/8137/abstract/28\">",
"     28",
"    </a>",
"    ]. Spontaneous recovery occurs within 24 months in the majority of patients (95 percent in one study) [",
"    <a class=\"abstract\" href=\"UTD.htm?7/60/8137/abstract/26,27\">",
"     26,27",
"    </a>",
"    ]. Until they recover, children with this disorder are subject to recurrent, albeit mild, infection [",
"    <a class=\"abstract\" href=\"UTD.htm?7/60/8137/abstract/26,29\">",
"     26,29",
"    </a>",
"    ]. Although the neutropenia is severe (ANC less than",
"    <span class=\"nowrap\">",
"     500/microL),",
"    </span>",
"    the ANC can rise temporarily in response to acute infection. This temporary increase in neutrophil count can help in attenuating the severity of acute infection but has little effect on periodontal disease, which is a chronic infection. Severe gingivitis and periodontal disease may result without preventive measures.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Cyclic neutropenia",
"    </span>",
"    &nbsp;&mdash;&nbsp;Cyclic neutropenia is characterized by regular oscillations in the numbers of circulating neutrophils, monocytes, eosinophils, lymphocytes, and reticulocytes [",
"    <a class=\"abstract\" href=\"UTD.htm?7/60/8137/abstract/30-32\">",
"     30-32",
"    </a>",
"    ]. The cycles typically occur at 21-day intervals, but the intervals can range from 15 to 35 days. Neutrophil counts fluctuate between normal and less than",
"    <span class=\"nowrap\">",
"     500/microL",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?7/60/8137/abstract/32\">",
"     32",
"    </a>",
"    ]. The monocyte, eosinophil, platelet, and reticulocyte oscillations usually fluctuate from normal to high levels, and the periodicity of these cycles is typically the same as that for the neutrophils [",
"    <a class=\"abstract\" href=\"UTD.htm?7/60/8137/abstract/31\">",
"     31",
"    </a>",
"    ]. During periods of neutropenia, the bone marrow is usually hypoplastic, with myelocyte arrest [",
"    <a class=\"abstract\" href=\"UTD.htm?7/60/8137/abstract/33\">",
"     33",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/61/42966?source=see_link\">",
"     \"Cyclic neutropenia\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Cyclic neutropenia can have onset in childhood or adulthood. Childhood onset is more common and appears to be a genetic condition with autosomal dominant inheritance [",
"    <a class=\"abstract\" href=\"UTD.htm?7/60/8137/abstract/32,34\">",
"     32,34",
"    </a>",
"    ]. Among families with autosomal dominant disease, the spectrum of severity ranges from asymptomatic to life-threatening [",
"    <a class=\"abstract\" href=\"UTD.htm?7/60/8137/abstract/34\">",
"     34",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Periods of severe neutropenia typically last one week during each cycle; during these periods, patients are prone to malaise, fever, aphthous stomatitis, and occasionally serious cutaneous and subcutaneous infections [",
"    <a class=\"abstract\" href=\"UTD.htm?7/60/8137/abstract/30,31\">",
"     30,31",
"    </a>",
"    ]. The severity of infections varies in relation to the severity of neutropenia. Gingival inflammation, edema, and recession can occur; alveolar bone support may be lost in the preschool-age child, resulting in premature tooth mobility and loss (",
"    <a class=\"graphic graphic_picture graphicRef79500 \" href=\"UTD.htm?2/40/2689\">",
"     picture 3",
"    </a>",
"    ). Without vigilant management, death from infection is a possibility [",
"    <a class=\"abstract\" href=\"UTD.htm?7/60/8137/abstract/33\">",
"     33",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The diagnosis and treatment of cyclic neutropenia are discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/61/42966?source=see_link\">",
"     \"Cyclic neutropenia\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Dental management",
"    </span>",
"    &nbsp;&mdash;&nbsp;Early dental referral and highly motivated parents are the keys to successful dental management of children with neutropenia. Neutropenia predisposes the child to hemorrhagic gingivitis and periodontal disease, but the progression of bone loss is because of the host response to pathogenic subgingival plaque. Thus, scrupulous oral hygiene, antimicrobial rinses, frequent professional tooth cleaning, and targeted antibiotic therapy can delay or halt periodontal bone loss.",
"   </p>",
"   <p>",
"    Antibiotic therapy for neutropenic children with periodontal disease is determined by microbial cultures of the gingival sulcus. The organisms most commonly cultured in children with periodontal disease include Prevotella intermedia, Actinobacillus actinomycetemcomitans, Eikenella corrodens, and Capnocytophaga sputigena [",
"    <a class=\"abstract\" href=\"UTD.htm?7/60/8137/abstract/35\">",
"     35",
"    </a>",
"    ]. Eradication and control of these pathogens is essential in the treatment of periodontal disease. Periodic surveillance cultures will help to determine the need for repetition of antibiotic therapy.",
"   </p>",
"   <p>",
"    The treatment of neutropenic children with periodontal disease is usually more successful in children with localized than with generalized periodontal disease; generalized periodontal disease may be refractory to antibiotic therapy without correction of the underlying neutrophil defect. Treatment of the underlying disorder with administration of G-CSF, and normalization of neutrophil counts, may not be sufficient to maintain oral health because of possible associated functional neutrophil defects; this underscores the significance of professional dental care for such patients [",
"    <a class=\"abstract\" href=\"UTD.htm?7/60/8137/abstract/36\">",
"     36",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h1\">",
"     DIABETES MELLITUS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with type 1 and type 2 diabetes mellitus have an increased risk for and earlier onset of periodontal disease, probably related to impaired immune function [",
"    <a class=\"abstract\" href=\"UTD.htm?7/60/8137/abstract/37-40\">",
"     37-40",
"    </a>",
"    ]. Periodontal disease is present in 10 to 15 percent of adolescents with type 1 diabetes. In children and adolescents with type 2 diabetes, periodontal destruction appears to be associated with components of the metabolic syndrome and beta cell function [",
"    <a class=\"abstract\" href=\"UTD.htm?7/60/8137/abstract/41\">",
"     41",
"    </a>",
"    ]. Poor metabolic control increases the risk of periodontal disease through altered neutrophil chemotaxis [",
"    <a class=\"abstract\" href=\"UTD.htm?7/60/8137/abstract/42\">",
"     42",
"    </a>",
"    ]. Children with poorly controlled diabetes tend to have poorer oral hygiene practices [",
"    <a class=\"abstract\" href=\"UTD.htm?7/60/8137/abstract/43\">",
"     43",
"    </a>",
"    ] and have an increased plaque index and more severe gingivitis than healthy children [",
"    <a class=\"abstract\" href=\"UTD.htm?7/60/8137/abstract/44-47\">",
"     44-47",
"    </a>",
"    ]. Periodontal disease, in turn, worsens diabetes control [",
"    <a class=\"abstract\" href=\"UTD.htm?7/60/8137/abstract/48\">",
"     48",
"    </a>",
"    ]. Glucose control, oral hygiene, and early diagnosis and treatment of periodontal disease are important for the overall health of children with diabetes. Children with diabetes mellitus may have accelerated tooth eruption. (See",
"    <a class=\"local\" href=\"#H4\">",
"     'Leukocyte adhesion deficiency'",
"    </a>",
"    above and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?38/42/39590?source=see_link&amp;anchor=H17#H17\">",
"     \"Anatomy and development of the teeth\", section on 'Accelerated eruption'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h1\">",
"     HYPOPHOSPHATASIA",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hypophosphatasia is a rare autosomal disease caused by a deficiency of tissue-nonspecific alkaline phosphatase and characterized by abnormal mineralization of bone and dental tissues [",
"    <a class=\"abstract\" href=\"UTD.htm?7/60/8137/abstract/49-55\">",
"     49-55",
"    </a>",
"    ]. It is caused by mutations in the tissue-non-specific alkaline phosphatase (",
"    <em>",
"     TNSALP",
"    </em>",
"    ) gene [",
"    <a class=\"abstract\" href=\"UTD.htm?7/60/8137/abstract/56\">",
"     56",
"    </a>",
"    ]. The phenotypic appearance varies. As a general rule, the earlier the presentation, the more severe the disease. Early loss of primary incisors may be the first and only sign in mild disease (",
"    <a class=\"graphic graphic_picture graphicRef50982 \" href=\"UTD.htm?13/6/13408\">",
"     picture 4",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    The severe forms of the disease are autosomal recessive and present in the perinatal period (usually lethal) and in infancy. Patients with the infantile form present within the first six months of life with generalized skeletal demineralization, hypercalcemia, hypercalciuria, fractures, craniosynostosis, short extremities, failure to thrive, and respiratory infections [",
"    <a class=\"abstract\" href=\"UTD.htm?7/60/8137/abstract/57\">",
"     57",
"    </a>",
"    ]. These clinical features are reproduced in mice in which the genes for alkaline phosphatase have been deleted [",
"    <a class=\"abstract\" href=\"UTD.htm?7/60/8137/abstract/58\">",
"     58",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The childhood and adult forms are less severe than the infantile form and can be dominant or recessive [",
"    <a class=\"abstract\" href=\"UTD.htm?7/60/8137/abstract/51,52,59,60\">",
"     51,52,59,60",
"    </a>",
"    ]. They have variable penetrance and expression but typically present with premature loss of deciduous teeth. The extraoral manifestations of childhood hypophosphatasia include craniosynostosis, short stature, bone pain, spontaneous fractures, and scoliosis. Demineralization and rachitic changes can be seen on radiographs [",
"    <a class=\"abstract\" href=\"UTD.htm?7/60/8137/abstract/57\">",
"     57",
"    </a>",
"    ]. Muscle pain, stiffness, and proximal lower-limb weakness also may occur [",
"    <a class=\"abstract\" href=\"UTD.htm?7/60/8137/abstract/61\">",
"     61",
"    </a>",
"    ]. In the adult form, dental disease often precedes the onset of symptomatic osteomalacia.",
"   </p>",
"   <p>",
"    Hypophosphatasia leads to complete absence or marked reduction in the amount of cementum covering the root's surface [",
"    <a class=\"abstract\" href=\"UTD.htm?7/60/8137/abstract/62\">",
"     62",
"    </a>",
"    ]. The absence of cementum prevents normal anchoring of the fibers of the periodontal ligament and leads to premature tooth mobility and loss. The periodontal microflora of children with hypophosphatasia appear to be no different from that of healthy controls [",
"    <a class=\"abstract\" href=\"UTD.htm?7/60/8137/abstract/63\">",
"     63",
"    </a>",
"    ]. Lower alkaline phosphatase activity and lower capacity for forming mineralized nodules by pulpal cells in hypophosphatasia may contribute to dentin dysplasia [",
"    <a class=\"abstract\" href=\"UTD.htm?7/60/8137/abstract/64\">",
"     64",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The teeth are affected in the order of formation; those that form earliest are more severely involved. Approximately three-quarters of affected children have premature exfoliation of primary teeth. Exfoliation of the primary incisors typically occurs before four years of age and may occur as early as 18 months of age in more severe disease. The other primary teeth are affected to varying degrees, and the permanent dentition usually is normal [",
"    <a class=\"abstract\" href=\"UTD.htm?7/60/8137/abstract/50\">",
"     50",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Hypophosphatasia is diagnosed through blood sampling that demonstrates low serum alkaline phosphatase concentration or elevated concentrations of phosphoethanolamine and pyrophosphate. Affected patients also may have increased urinary excretion of phosphoethanolamine [",
"    <a class=\"abstract\" href=\"UTD.htm?7/60/8137/abstract/46\">",
"     46",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    No uniformly successful treatment for hypophosphatasia is known. Palliative therapy for the infantile form may include correction of hypercalcemia (with calcitonin), reduction of hypercalciuria (with",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?20/27/20919?source=see_link\">",
"     chlorothiazide",
"    </a>",
"    ), reduction of dietary intake of calcium and vitamin D, and reduced exposure to sunlight. Secondary rickets can be prevented through the administration of between 200 and 400 IU of vitamin D per day. Serial monitoring of 25-hydroxyvitamin D levels is necessary to monitor and titrate intake [",
"    <a class=\"abstract\" href=\"UTD.htm?7/60/8137/abstract/57,61\">",
"     57,61",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h1\">",
"     DOWN SYNDROME",
"    </span>",
"    &nbsp;&mdash;&nbsp;Individuals with Down syndrome have increased susceptibility to periodontal disease. Periodontal disease may be present in the primary dentition and develops in most patients by 30 years of age. The severity of periodontal destruction is greater than can be attributed to the increased levels of plaque in these patients [",
"    <a class=\"abstract\" href=\"UTD.htm?7/60/8137/abstract/65\">",
"     65",
"    </a>",
"    ]. The periodontal involvement in Down syndrome patients has negative effects on quality of life [",
"    <a class=\"abstract\" href=\"UTD.htm?7/60/8137/abstract/66\">",
"     66",
"    </a>",
"    ]. Down syndrome is associated with abnormalities in the immune system, particularly lymphocyte function, which may contribute to their increased susceptibility to periodontal disease [",
"    <a class=\"abstract\" href=\"UTD.htm?7/60/8137/abstract/67\">",
"     67",
"    </a>",
"    ]. In addition, patients with Down syndrome commonly have high attachment of the anterior mandibular frenum that is associated with gingival recession [",
"    <a class=\"abstract\" href=\"UTD.htm?7/60/8137/abstract/65\">",
"     65",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/15/26874?source=see_link\">",
"     \"Clinical features and diagnosis of Down syndrome\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?29/32/30216?source=see_link&amp;anchor=H4#H4\">",
"     \"Soft tissue lesions of the oral cavity in children\", section on 'Frenum'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h1\">",
"     PAPILLON-LEF&Egrave;VRE SYNDROME",
"    </span>",
"    &nbsp;&mdash;&nbsp;The Papillon-Lef&egrave;vre syndrome is characterized by premature loss of the primary and permanent teeth and hyperkeratosis of the palms, soles, and sometimes of the knees and elbows. It is caused by mutations in the cathepsin C gene (CTSC) on chromosome 11q14 [",
"    <a class=\"abstract\" href=\"UTD.htm?7/60/8137/abstract/68-70\">",
"     68-70",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The periodontal inflammation begins soon after eruption of the primary teeth. Bone loss is rapid and severe; primary teeth are lost by three to five years of age and permanent teeth within a few years of eruption (",
"    <a class=\"graphic graphic_picture graphicRef66117 \" href=\"UTD.htm?9/45/9951\">",
"     picture 5",
"    </a>",
"    ). The severity of disease may be related to immunologic and microbiologic factors. Patients with Papillon-Lef&egrave;vre have abnormalities in neutrophil and natural killer cell function [",
"    <a class=\"abstract\" href=\"UTD.htm?7/60/8137/abstract/69-73\">",
"     69-73",
"    </a>",
"    ]. The organisms typically cultured from the gingival sulcus of patients with Papillon-Lef&egrave;vre syndrome are similar to those cultured from children who have neutropenia, and include",
"    <em>",
"     Actinobacillus actinomycetemcomitans",
"    </em>",
"    ,",
"    <em>",
"     Capnocytophaga",
"    </em>",
"    species,",
"    <em>",
"     Fusobacterium nudeatum",
"    </em>",
"    , and",
"    <em>",
"     Eikenella corrodens",
"    </em>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?7/60/8137/abstract/74,75\">",
"     74,75",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Recommended periodontal treatment of young children with Papillon-Lef&egrave;vre syndrome thus includes identification of specific periodontal pathogens and antibiotic therapy targeted to these microorganisms [",
"    <a class=\"abstract\" href=\"UTD.htm?7/60/8137/abstract/76\">",
"     76",
"    </a>",
"    ]. In cases where these measures are unsuccessful, extraction of all erupted teeth or treatment with retinoids has been reported to preserve the unerupted permanent teeth [",
"    <a class=\"abstract\" href=\"UTD.htm?7/60/8137/abstract/55,74,76,77\">",
"     55,74,76,77",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h1\">",
"     INFECTIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Infections associated with oral lesions are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?29/32/30216?source=see_link&amp;anchor=H21#H21\">",
"     \"Soft tissue lesions of the oral cavity in children\", section on 'Infections'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"   </p>",
"   <p>",
"    Systemic conditions associated with childhood periodontitis include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Langerhans cell histiocytosis (LCH). Dental presentations of LCH include eruption of the primary molars at or soon after birth (",
"      <a class=\"graphic graphic_picture graphicRef70097 \" href=\"UTD.htm?18/31/18942\">",
"       picture 1",
"      </a>",
"      ), aggressive periodontitis lesions that do not respond to routine periodontal therapy, and dental radiographs demonstrating discreet, destructive bone lesions that make the teeth appear to be \"floating on air\". (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Histiocytosis'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?20/53/21338?source=see_link\">",
"       \"Clinical manifestations, pathologic features, and diagnosis of Langerhans cell histiocytosis\"",
"      </a>",
"      .).",
"     </li>",
"     <li>",
"      Leukemia. Leukemia should be considered in patients who have hemorrhagic gingival edema and anemia, thrombocytopenia, or abnormal leukocyte and differential counts on complete blood count. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Leukemia'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?3/58/4009?source=see_link\">",
"       \"Overview of the presentation and classification of acute lymphoblastic leukemia in children\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Leukocyte adhesion deficiency (LAD). Oral manifestations of LAD, which are seen in the early primary dentition, include severe gingival inflammation; rapid bone loss around nearly all teeth; and mobility and premature loss of teeth. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Leukocyte adhesion deficiency'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?42/38/43620?source=see_link&amp;anchor=H5#H5\">",
"       \"Primary disorders of phagocytic function: An overview\", section on 'Leukocyte adhesion deficiencies'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Neutropenia. Children with congenital, autoimmune, or cyclic neutropenia are predisposed to hemorrhagic gingivitis and periodontal disease, potentially complicated by alveolar bone loss, tooth mobility (",
"      <a class=\"graphic graphic_picture graphicRef79500 \" href=\"UTD.htm?2/40/2689\">",
"       picture 3",
"      </a>",
"      ), and premature exfoliation. Scrupulous oral hygiene, antimicrobial rinses, frequent professional tooth cleaning, and targeted antibiotic therapy are the keys to successful dental management. (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Neutropenia'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?24/22/24937?source=see_link\">",
"       \"Congenital neutropenia\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?41/33/42520?source=see_link&amp;anchor=H4#H4\">",
"       \"Immune neutropenia\", section on 'Autoimmune neutropenia'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?41/61/42966?source=see_link\">",
"       \"Cyclic neutropenia\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Diabetes mellitus. Patients with type 1 and type 2 diabetes mellitus have an increased risk for and earlier onset of periodontal disease. Poor metabolic control increases the risk of periodontal disease. (See",
"      <a class=\"local\" href=\"#H10\">",
"       'Diabetes mellitus'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Hypophosphatasia. Hypophosphatasia is a rare disease characterized by abnormal mineralization of bone and dental tissues. Oral manifestations include premature loss of deciduous teeth. Exfoliation of the primary incisors typically occurs before four years of age and may occur as early as 18 months of age in more severe disease (",
"      <a class=\"graphic graphic_picture graphicRef50982 \" href=\"UTD.htm?13/6/13408\">",
"       picture 4",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H11\">",
"       'Hypophosphatasia'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Down syndrome. Individuals with Down syndrome have increased susceptibility to periodontal disease. (See",
"      <a class=\"local\" href=\"#H12\">",
"       'Down syndrome'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Papillon-Lef&egrave;vre syndrome. The Papillon-Lef&egrave;vre syndrome is characterized by premature loss of the primary and permanent teeth and hyperkeratosis of the palms, soles, and sometimes of the knees and elbows. Periodontal inflammation begins soon after eruption of the primary teeth. Bone loss is rapid and severe; primary teeth are lost by three to five years of age and permanent teeth within a few years of eruption (",
"      <a class=\"graphic graphic_picture graphicRef66117 \" href=\"UTD.htm?9/45/9951\">",
"       picture 5",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H13\">",
"       'Papillon-Lef&egrave;vre syndrome'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     Laskaris, G, Scully, C. Periodontal manifestations of local and systemic diseases: colour atlas and text. Springer, Berlin, New York 2003.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/60/8137/abstract/2\">",
"      Henry RJ, Sweeney EA. Langerhans' cell histiocytosis: case reports and literature review. Pediatr Dent 1996; 18:11.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/60/8137/abstract/3\">",
"      Hartman KS. Histiocytosis X: a review of 114 cases with oral involvement. Oral Surg Oral Med Oral Pathol 1980; 49:38.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/60/8137/abstract/4\">",
"      Ardekian L, Peled M, Rosen D, et al. Clinical and radiographic features of eosinophilic granuloma in the jaws: review of 41 lesions treated by surgery and low-dose radiotherapy. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1999; 87:238.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/60/8137/abstract/5\">",
"      Guiglia R, Pizzo G, Aric&ograve; M, et al. Bifocal manifestation of eosinophilic granuloma in a pediatric patient. Med Sci Monit 2009; 15:CS95.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/60/8137/abstract/6\">",
"      Dagenais M, Pharoah MJ, Sikorski PA. The radiographic characteristics of histiocytosis X. A study of 29 cases that involve the jaws. Oral Surg Oral Med Oral Pathol 1992; 74:230.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/60/8137/abstract/7\">",
"      Silvestros SS, Mamalis AA, Sklavounou AD, et al. Eosinophilic granuloma masquerading as aggressive periodontitis. J Periodontol 2006; 77:917.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/60/8137/abstract/8\">",
"      Torrungruang K, Sittisomwong S, Rojanasomsith K, et al. Langerhans' cell histiocytosis in a 5-year-old girl: evidence of periodontal pathogens. J Periodontol 2006; 77:728.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/60/8137/abstract/9\">",
"      Klein F, Krigar D, Petzoldt D, Eickholz P. Periodontal manifestation of Langerhans' cell histiocytosis in a young man: case report with a 24-month follow-up. Quintessence Int 2006; 37:175.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/60/8137/abstract/10\">",
"      Delaney JE, Keels MA. Pediatric oral pathology. Soft tissue and periodontal conditions. Pediatr Clin North Am 2000; 47:1125.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/60/8137/abstract/11\">",
"      Weckx LL, Hidal LB, Marcucci G. Oral manifestations of leukemia. Ear Nose Throat J 1990; 69:341.",
"     </a>",
"    </li>",
"    <li>",
"     Oral Pathology: Clinical-Pathologic Correlations, 2nd, Regezi JA, Sciubba J (Eds), WB Saunders, Philadelphia 1993. p.196.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/60/8137/abstract/13\">",
"      Peterson DE, D'Ambrosio JA. Nonsurgical management of head and neck cancer patients. Dent Clin North Am 1994; 38:425.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/60/8137/abstract/14\">",
"      Otsubo H, Yokoe H, Miya T, et al. Gingival squamous cell carcinoma in a patient with chronic graft-versus-host disease. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1997; 84:171.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/60/8137/abstract/15\">",
"      Ponce-Torres E, Ru&iacute;z-Rodr&iacute;guez Mdel S, Alejo-Gonz&aacute;lez F, et al. Oral manifestations in pediatric patients receiving chemotherapy for acute lymphoblastic leukemia. J Clin Pediatr Dent 2010; 34:275.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/60/8137/abstract/16\">",
"      de Oliveira Lula EC, de Oliveira Lula CE, Alves CM, et al. Chemotherapy-induced oral complications in leukemic patients. Int J Pediatr Otorhinolaryngol 2007; 71:1681.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/60/8137/abstract/17\">",
"      Consensus statement: oral complications of cancer therapies. National Institutes of Health Consensus Development Panel. NCI Monogr 1990; :3.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/60/8137/abstract/18\">",
"      Childers NK, Stinnett EA, Wheeler P, et al. Oral complications in children with cancer. Oral Surg Oral Med Oral Pathol 1993; 75:41.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/60/8137/abstract/19\">",
"      Sonis S, Kunz A. Impact of improved dental services on the frequency of oral complications of cancer therapy for patients with non-head-and-neck malignancies. Oral Surg Oral Med Oral Pathol 1988; 65:19.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/60/8137/abstract/20\">",
"      da Fonseca MA. Pediatric bone marrow transplantation: oral complications and recommendations for care. Pediatr Dent 1998; 20:386.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/60/8137/abstract/21\">",
"      Watanabe K. Prepubertal periodontitis: a review of diagnostic criteria, pathogenesis, and differential diagnosis. J Periodontal Res 1990; 25:31.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/60/8137/abstract/22\">",
"      Roberts MW, Atkinson JC. Oral manifestations associated with leukocyte adhesion deficiency: a five-year case study. Pediatr Dent 1990; 12:107.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/60/8137/abstract/23\">",
"      Berrocal T, Sim&oacute;n MJ, al-Assir I, et al. Shwachman-Diamond syndrome: clinical, radiological and sonographic findings. Pediatr Radiol 1995; 25:356.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/60/8137/abstract/24\">",
"      Ye Y, Carlsson G, Wondimu B, et al. Mutations in the ELANE gene are associated with development of periodontitis in patients with severe congenital neutropenia. J Clin Immunol 2011; 31:936.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/60/8137/abstract/25\">",
"      Logue GL, Shimm DS. Autoimmune granulocytopenia. Annu Rev Med 1980; 31:191.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/60/8137/abstract/26\">",
"      Bux J, Behrens G, Jaeger G, Welte K. Diagnosis and clinical course of autoimmune neutropenia in infancy: analysis of 240 cases. Blood 1998; 91:181.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/60/8137/abstract/27\">",
"      Lalezari P, Khorshidi M, Petrosova M. Autoimmune neutropenia of infancy. J Pediatr 1986; 109:764.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/60/8137/abstract/28\">",
"      Bux J, Kissel K, Nowak K, et al. Autoimmune neutropenia: clinical and laboratory studies in 143 patients. Ann Hematol 1991; 63:249.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/60/8137/abstract/29\">",
"      Neglia JP, Watterson J, Clay M, et al. Autoimmune neutropenia of infancy and early childhood. Pediatr Hematol Oncol 1993; 10:369.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/60/8137/abstract/30\">",
"      Wright DG, Dale DC, Fauci AS, Wolff SM. Human cyclic neutropenia: clinical review and long-term follow-up of patients. Medicine (Baltimore) 1981; 60:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/60/8137/abstract/31\">",
"      Haurie C, Dale DC, Mackey MC. Cyclical neutropenia and other periodic hematological disorders: a review of mechanisms and mathematical models. Blood 1998; 92:2629.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/60/8137/abstract/32\">",
"      Dale DC, Hammond WP 4th. Cyclic neutropenia: a clinical review. Blood Rev 1988; 2:178.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/60/8137/abstract/33\">",
"      Lange RD, Jones JB. Cyclic neutropenia. Review of clinical manifestations and management. Am J Pediatr Hematol Oncol 1981; 3:363.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/60/8137/abstract/34\">",
"      Palmer SE, Stephens K, Dale DC. Genetics, phenotype, and natural history of autosomal dominant cyclic hematopoiesis. Am J Med Genet 1996; 66:413.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/60/8137/abstract/35\">",
"      Delaney JE, Kornman KS. Microbiology of subgingival plaque from children with localized prepubertal periodontitis. Oral Microbiol Immunol 1987; 2:71.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/60/8137/abstract/36\">",
"      Carlsson G, Wahlin YB, Johansson A, et al. Periodontal disease in patients from the original Kostmann family with severe congenital neutropenia. J Periodontol 2006; 77:744.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/60/8137/abstract/37\">",
"      Iughetti L, Marino R, Bertolani MF, Bernasconi S. Oral health in children and adolescents with IDDM--a review. J Pediatr Endocrinol Metab 1999; 12:603.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/60/8137/abstract/38\">",
"      Grossi SG, Genco RJ, Machtei EE, et al. Assessment of risk for periodontal disease. II. Risk indicators for alveolar bone loss. J Periodontol 1995; 66:23.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/60/8137/abstract/39\">",
"      Taylor GW, Burt BA, Becker MP, et al. Non-insulin dependent diabetes mellitus and alveolar bone loss progression over 2 years. J Periodontol 1998; 69:76.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/60/8137/abstract/40\">",
"      Lalla E, Cheng B, Lal S, et al. Periodontal changes in children and adolescents with diabetes: a case-control study. Diabetes Care 2006; 29:295.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/60/8137/abstract/41\">",
"      Merchant AT, Jethwani M, Choi YH, et al. Associations between periodontal disease and selected risk factors of early complications among youth with type 1 and type 2 diabetes: a pilot study. Pediatr Diabetes 2011; 12:529.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/60/8137/abstract/42\">",
"      Lalla E, Cheng B, Lal S, et al. Diabetes-related parameters and periodontal conditions in children. J Periodontal Res 2007; 42:345.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/60/8137/abstract/43\">",
"      Merchant AT, Oranbandid S, Jethwani M, et al. Oral care practices and A1c among youth with type 1 and type 2 diabetes. J Periodontol 2012; 83:856.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/60/8137/abstract/44\">",
"      Harrison R, Bowen WH. Periodontal health, dental caries, and metabolic control in insulin-dependent diabetic children and adolescents. Pediatr Dent 1987; 9:283.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/60/8137/abstract/45\">",
"      de Pommereau V, Dargent-Par&eacute; C, Robert JJ, Brion M. Periodontal status in insulin-dependent diabetic adolescents. J Clin Periodontol 1992; 19:628.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/60/8137/abstract/46\">",
"      Lundgren T, Westphal O, Bolme P, et al. Retrospective study of children with hypophosphatasia with reference to dental changes. Scand J Dent Res 1991; 99:357.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/60/8137/abstract/47\">",
"      Karjalainen KM, Knuuttila ML. The onset of diabetes and poor metabolic control increases gingival bleeding in children and adolescents with insulin-dependent diabetes mellitus. J Clin Periodontol 1996; 23:1060.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/60/8137/abstract/48\">",
"      Lakschevitz F, Aboodi G, Tenenbaum H, Glogauer M. Diabetes and periodontal diseases: interplay and links. Curr Diabetes Rev 2011; 7:433.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/60/8137/abstract/49\">",
"      Hu CC, King DL, Thomas HF, Simmer JP. A clinical and research protocol for characterizing patients with hypophosphatasia. Pediatr Dent 1996; 18:17.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/60/8137/abstract/50\">",
"      Chapple IL. Hypophosphatasia: dental aspects and mode of inheritance. J Clin Periodontol 1993; 20:615.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/60/8137/abstract/51\">",
"      Whyte MP, Teitelbaum SL, Murphy WA, et al. Adult hypophosphatasia. Clinical, laboratory, and genetic investigation of a large kindred with review of the literature. Medicine (Baltimore) 1979; 58:329.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/60/8137/abstract/52\">",
"      Fallon MD, Teitelbaum SL, Weinstein RS, et al. Hypophosphatasia: clinicopathologic comparison of the infantile, childhood, and adult forms. Medicine (Baltimore) 1984; 63:12.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/60/8137/abstract/53\">",
"      Silve C. Hereditary hypophosphatasia and hyperphosphatasia. Curr Opin Rheumatol 1994; 6:336.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/60/8137/abstract/54\">",
"      Moore CA, Curry CJ, Henthorn PS, et al. Mild autosomal dominant hypophosphatasia: in utero presentation in two families. Am J Med Genet 1999; 86:410.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/60/8137/abstract/55\">",
"      Deeb AA, Bruce SN, Morris AA, Cheetham TD. Infantile hypophosphatasia: disappointing results of treatment. Acta Paediatr 2000; 89:730.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/60/8137/abstract/56\">",
"      Taillandier A, Lia-Baldini AS, Mouchard M, et al. Twelve novel mutations in the tissue-nonspecific alkaline phosphatase gene (ALPL) in patients with various forms of hypophosphatasia. Hum Mutat 2001; 18:83.",
"     </a>",
"    </li>",
"    <li>",
"     Wappner, RS. Inborn errors associated with faulty bone mineralization. In: Oski's Pediatrics. Principles and Practice, 4th ed, McMillan, JA, Feigin, RD, DeAngelis, C, Jones, MD (Eds), Lippincott, Williams &amp; Wilkins, Philadelphia 2006. p.2238.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/60/8137/abstract/58\">",
"      Fedde KN, Blair L, Silverstein J, et al. Alkaline phosphatase knock-out mice recapitulate the metabolic and skeletal defects of infantile hypophosphatasia. J Bone Miner Res 1999; 14:2015.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/60/8137/abstract/59\">",
"      Seshia SS, Derbyshire G, Haworth JC, Hoogstraten J. Myopathy with hypophosphatasia. Arch Dis Child 1990; 65:130.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/60/8137/abstract/60\">",
"      Lepe X, Rothwell BR, Banich S, Page RC. Absence of adult dental anomalies in familial hypophosphatasia. J Periodontal Res 1997; 32:375.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/60/8137/abstract/61\">",
"      Barcia JP, Strife CF, Langman CB. Infantile hypophosphatasia: treatment options to control hypercalcemia, hypercalciuria, and chronic bone demineralization. J Pediatr 1997; 130:825.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/60/8137/abstract/62\">",
"      van den Bos T, Handoko G, Niehof A, et al. Cementum and dentin in hypophosphatasia. J Dent Res 2005; 84:1021.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/60/8137/abstract/63\">",
"      Valenza G, Burgemeister S, Girschick H, et al. Analysis of the periodontal microbiota in childhood-type hypophosphatasia. Int J Med Microbiol 2006; 296:493.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/60/8137/abstract/64\">",
"      Liu H, Li J, Lei H, et al. Genetic etiology and dental pulp cell deficiency of hypophosphatasia. J Dent Res 2010; 89:1373.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/60/8137/abstract/65\">",
"      Reuland-Bosma W, van Dijk J. Periodontal disease in Down's syndrome: a review. J Clin Periodontol 1986; 13:64.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/60/8137/abstract/66\">",
"      Amaral Loureiro AC, Oliveira Costa F, Eust&aacute;quio da Costa J. The impact of periodontal disease on the quality of life of individuals with Down syndrome. Downs Syndr Res Pract 2007; 12:50.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/60/8137/abstract/67\">",
"      Kusters MA, Verstegen RH, Gemen EF, de Vries E. Intrinsic defect of the immune system in children with Down syndrome: a review. Clin Exp Immunol 2009; 156:189.",
"     </a>",
"    </li>",
"    <li>",
"     Papillon-Lef&egrave;vre syndrome. In: Mendelian Inheritance in Man. Johns Hopkins University. Available at www.ncbi.nlm.nih.gov:80/entrez/dispomim.cgi?id=245000. (Accessed on February 2, 2008).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/60/8137/abstract/69\">",
"      Ghaffer KA, Zahran FM, Fahmy HM, Brown RS. Papillon-Lef&egrave;vre syndrome: neutrophil function in 15 cases fron 4 families in Egypt. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1999; 88:320.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/60/8137/abstract/70\">",
"      Firatli E, T&uuml;z&uuml;n B, Efeolu A. Papillon-Lef&egrave;vre syndrome. Analysis of neutrophil chemotaxis. J Periodontol 1996; 67:617.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/60/8137/abstract/71\">",
"      Ishikawa I, Umeda M, Laosrisin N. Clinical, bacteriological, and immunological examinations and the treatment process of two Papillon-Lef&egrave;vre syndrome patients. J Periodontol 1994; 65:364.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/60/8137/abstract/72\">",
"      Lundgren T, Parhar RS, Renvert S, Tatakis DN. Impaired cytotoxicity in Papillon-Lef&egrave;vre syndrome. J Dent Res 2005; 84:414.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/60/8137/abstract/73\">",
"      de Haar SF, Hiemstra PS, van Steenbergen MT, et al. Role of polymorphonuclear leukocyte-derived serine proteinases in defense against Actinobacillus actinomycetemcomitans. Infect Immun 2006; 74:5284.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/60/8137/abstract/74\">",
"      Preus H, Gjermo P. Clinical management of prepubertal periodontitis in 2 siblings with Papillon-Lef&egrave;vre syndrome. J Clin Periodontol 1987; 14:156.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/60/8137/abstract/75\">",
"      Wiebe CB, H&auml;kkinen L, Putnins EE, et al. Successful periodontal maintenance of a case with Papillon-Lef&egrave;vre syndrome: 12-year follow-up and review of the literature. J Periodontol 2001; 72:824.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/60/8137/abstract/76\">",
"      Tinanoff N, Tempro P, Maderazo EG. Dental treatment of Papillon-Lef&egrave;vre syndrome: 15-year follow-up. J Clin Periodontol 1995; 22:609.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/60/8137/abstract/77\">",
"      Kressin S, Herforth A, Preis S, et al. Papillon-Lef&egrave;vre syndrome--successful treatment with a combination of retinoid and concurrent systematic periodontal therapy: case reports. Quintessence Int 1995; 26:795.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 6281 Version 5.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-125.69.132.100-7288C09AE7-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f7_60_8137=[""].join("\n");
var outline_f7_60_8137=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H15\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      HISTIOCYTOSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      LEUKEMIA",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      LEUKOCYTE ADHESION DEFICIENCY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      NEUTROPENIA",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Congenital",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Autoimmune",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Cyclic neutropenia",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Dental management",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      DIABETES MELLITUS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      HYPOPHOSPHATASIA",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      DOWN SYNDROME",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      PAPILLON-LEF&Egrave;VRE SYNDROME",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      INFECTIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PEDS/6281\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PEDS/6281|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?18/31/18942\" title=\"picture 1\">",
"      Premature eruption",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?33/41/34462\" title=\"picture 2\">",
"      Mucositis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?2/40/2689\" title=\"picture 3\">",
"      Cyclic neutropenia periodontal disease",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?13/6/13408\" title=\"picture 4\">",
"      Hypophosphatasia dental effects",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?9/45/9951\" title=\"picture 5\">",
"      Papillon-Lefevre syndrome dental effects",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?38/42/39590?source=related_link\">",
"      Anatomy and development of the teeth",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/15/26874?source=related_link\">",
"      Clinical features and diagnosis of Down syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?20/53/21338?source=related_link\">",
"      Clinical manifestations, pathologic features, and diagnosis of Langerhans cell histiocytosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?24/22/24937?source=related_link\">",
"      Congenital neutropenia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?41/61/42966?source=related_link\">",
"      Cyclic neutropenia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?41/33/42520?source=related_link\">",
"      Immune neutropenia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?37/22/38250?source=related_link\">",
"      Oral toxicity associated with chemotherapy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?31/45/32471?source=related_link\">",
"      Overview of gingivitis and periodontitis in children and adolescents",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?17/47/18170?source=related_link\">",
"      Overview of neutropenia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?3/58/4009?source=related_link\">",
"      Overview of the presentation and classification of acute lymphoblastic leukemia in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?42/38/43620?source=related_link\">",
"      Primary disorders of phagocytic function: An overview",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?29/32/30216?source=related_link\">",
"      Soft tissue lesions of the oral cavity in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/45/28378?source=related_link\">",
"      Treatment of Langerhans cell histiocytosis",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f7_60_8138="Body lice in clothing";
var content_f7_60_8138=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PC%2F76146%7EDERM%2F73592&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PC%2F76146%7EDERM%2F73592&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Body lice in clothing",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 402px; height: 251px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Body lice nits tend to concentrate along the seams of clothing.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Photo courtesy of John T Crissey, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Pediculosis corporis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 399px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    This patient presented with widespread hyperpigmentation, lichenification and excoriations, most severe on his legs. His socks were covered with numerous nits and adult and immature lice.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Copyright &copy; Chris Ha, MD, Dermatlas; file://www.dermatlas.org.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f7_60_8138=[""].join("\n");
var outline_f7_60_8138=null;
var title_f7_60_8139="CRC tumor regression grade";
var content_f7_60_8139=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ONC%2F50210&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ONC%2F50210&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Colorectal cancer tumor regression grade",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Description",
"       </td>",
"       <td class=\"subtitle1\">",
"        Tumor regression grade",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        No viable cancer cells",
"       </td>",
"       <td>",
"        0 (complete response)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Single cells or small groups of cancer cells",
"       </td>",
"       <td>",
"        1 (moderate response)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Residual cancer outgrown by fibrosis",
"       </td>",
"       <td>",
"        2 (minimal response)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Minimal or no tumor kill; extensive residual cancer",
"       </td>",
"       <td>",
"        3 (poor response)",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Used with the permission of the American Joint Committee on Cancer (AJCC), Chicago, Illinois. The original source for this material is the AJCC Cancer Staging Manual, Seventh Edition (2010) published by Springer New York, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f7_60_8139=[""].join("\n");
var outline_f7_60_8139=null;
var title_f7_60_8140="Selected lysosomal storage disorders";
var content_f7_60_8140=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F63392&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F63392&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Selected lysosomal storage disorders",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Mucopolysaccharidoses (MPS)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        MPS I (Hurler, Hurler-Scheie, Scheie)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        MPS II (Hunter)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        MPS III (Sanfillippo)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        MPS IV (Morquio)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        MPS VI (Maroteaux-Lamy)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        MPS VII (Sly)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        MPS IX (Natowicz)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Sphingolipidoses",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        GM1-gangliosidosis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        GM2 gangliosidosis type 1 (Tay-Sachs)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        GM2 gangliosidosis type 2 (Sandhoff)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Fabry disease",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Farber disease",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Gaucher disease",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Niemann-Pick disease",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Krabbe disease",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Metachromatic luekodystrophy",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Oligosaccharidoses (glycoproteinoses)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Galactosialidosis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Fucosidosis types",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Mannosidosis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Aspartlyglucosaminuria",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Mucolipidosis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Mucolipidosis type I (Sialidosis)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Mucolipidosis type II (I-cell)*",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Mucolipidosis type III (pseudo-Hurler)*",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Mucolopidosis type IV (Sialolipidosis)",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     * These disorders are caused by the same enzyme deficiency (N-acetylglucosamyl phosphotransferase).",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f7_60_8140=[""].join("\n");
var outline_f7_60_8140=null;
var title_f7_60_8141="Prothrombin complex concentrates in ICH";
var content_f7_60_8141=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=HEME%2F54930&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=7\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=HEME%2F54930&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=7\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Use of prothrombin-complex concentrates in warfarin-associated intracerebral hemorrhage",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Study",
"       </td>",
"       <td class=\"subtitle1\">",
"        N",
"       </td>",
"       <td class=\"subtitle1\">",
"        Source",
"       </td>",
"       <td class=\"subtitle1\">",
"        Composition",
"       </td>",
"       <td class=\"subtitle1\">",
"        Median dose",
"       </td>",
"       <td class=\"subtitle1\">",
"        ICH enlargement",
"       </td>",
"       <td class=\"subtitle1\">",
"        Thrombosis",
"       </td>",
"       <td class=\"subtitle1\">",
"        Early mortality, percent",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Yasaka, et al. (2003)",
"       </td>",
"       <td>",
"        11*",
"       </td>",
"       <td>",
"        PPSB-HT Nichiyaku/ Nihon",
"       </td>",
"       <td>",
"        20&nbsp;international units&nbsp;of II, VII, IX, X&nbsp;and 380&nbsp;units of protein C/mL",
"       </td>",
"       <td>",
"        12.5 international units/kg (~900 international units)",
"       </td>",
"       <td>",
"        22 percent (2/9)*",
"       </td>",
"       <td>",
"        0 percent (0/11)",
"       </td>",
"       <td>",
"        11",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Sjoblom, et al. (2001)",
"       </td>",
"       <td>",
"        23",
"       </td>",
"       <td>",
"        Prothrompex-T/ Immuno",
"       </td>",
"       <td>",
"        II, VII, IX&nbsp;and X",
"       </td>",
"       <td>",
"        NR",
"       </td>",
"       <td>",
"        NR",
"       </td>",
"       <td>",
"        NR",
"       </td>",
"       <td>",
"        39",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Bertram, et al. (2000)",
"       </td>",
"       <td>",
"        11",
"       </td>",
"       <td>",
"        Not specified",
"       </td>",
"       <td>",
"        Not specified",
"       </td>",
"       <td>",
"        NR",
"       </td>",
"       <td>",
"        27 percent&nbsp;(3/11)",
"        <sup>",
"         &bull;",
"        </sup>",
"       </td>",
"       <td>",
"        27 percent&nbsp;(3/11)",
"        <sup>",
"         &bull;",
"        </sup>",
"       </td>",
"       <td>",
"        9",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Cartmill, et al. (2000)",
"       </td>",
"       <td>",
"        6",
"       </td>",
"       <td>",
"        IXa/BPL",
"       </td>",
"       <td>",
"        Not specified",
"       </td>",
"       <td>",
"        50 international units/kg",
"       </td>",
"       <td>",
"        NR",
"       </td>",
"       <td>",
"        0 percent (0/6)",
"       </td>",
"       <td>",
"        17",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Boulis, et al. (1999)",
"       </td>",
"       <td>",
"        3",
"       </td>",
"       <td>",
"        Konyne/ Bayer",
"       </td>",
"       <td>",
"        II (38 international units), VII (4 international units), IX (25 international units), X (38 international units)",
"       </td>",
"       <td>",
"        40 to 50 international units/kg",
"       </td>",
"       <td>",
"        NR",
"       </td>",
"       <td>",
"        0 percent (0/3)",
"       </td>",
"       <td>",
"        33",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Makris, et al. (1997)",
"       </td>",
"       <td>",
"        16",
"       </td>",
"       <td>",
"        Prothrombin-T/ Immuno or IXA/BPL",
"       </td>",
"       <td>",
"        II, VII, IX, X",
"       </td>",
"       <td>",
"        25 to 50 international units/kg",
"       </td>",
"       <td>",
"        NR",
"       </td>",
"       <td>",
"        0 percent (0/16)",
"       </td>",
"       <td>",
"        NR",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Fredriksson, et al. (1992)",
"       </td>",
"       <td>",
"        10",
"       </td>",
"       <td>",
"        Perconativ/ Kabi",
"       </td>",
"       <td>",
"        II (50 international units), IX (60 international units),&nbsp;and X (50 international units)/mL",
"       </td>",
"       <td>",
"        26 international units/kg (1930 international units)",
"       </td>",
"       <td>",
"        NR",
"       </td>",
"       <td>",
"        10 percent&nbsp;(1/10) - ?PCVs",
"       </td>",
"       <td>",
"        20",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     ICH: intracerebral hemorrhage; NR: not reported.",
"     <br>",
"      * Nine ICH plus one each subdural and epidural hematoma: one hematoma enlargement was associated with an INR of 2.7, which occurred 24 hours after initial correction by prothrombin complex concentrates without coadministration of vitamin K.",
"      <br>",
"       &bull; Enlargement of ICH occurred on days 2 and 3 associated with INRs of 1.5, 3.2, and 1.9 at the time of deterioration and receiving full dose (n=2) or low dose heparin. Of seven patients with prosthetic valves given prothrombin complex concentrate, two had middle cerebral artery ischemic strokes on treatment days 4 and 5.",
"      </br>",
"     </br>",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f7_60_8141=[""].join("\n");
var outline_f7_60_8141=null;
var title_f7_60_8142="Comb chemo reg HL";
var content_f7_60_8142=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ONC%2F74186&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ONC%2F74186&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Chemotherapeutic regimens used for the treatment of Hodgkin lymphoma",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Regimen",
"       </td>",
"       <td class=\"subtitle1\">",
"        Dosage and schedule",
"       </td>",
"       <td class=\"subtitle1\">",
"        Frequency",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"3\">",
"        ABVD",
"        <sup>",
"         [1]",
"        </sup>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Doxorubicin",
"       </td>",
"       <td>",
"        25 mg/m",
"        <sup>",
"         2",
"        </sup>",
"        IV on days 1 and 15",
"       </td>",
"       <td rowspan=\"4\">",
"        Repeat cycle every 28 days",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Bleomycin",
"       </td>",
"       <td>",
"        10 units*/m",
"        <sup>",
"         2",
"        </sup>",
"        IV on days 1 and 15",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Vinblastine",
"       </td>",
"       <td>",
"        6 mg/m",
"        <sup>",
"         2",
"        </sup>",
"        IV on days 1 and 15",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Dacarbazine",
"       </td>",
"       <td>",
"        375 mg/m",
"        <sup>",
"         2",
"        </sup>",
"        IV on days 1 and 15",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"3\">",
"        STANFORD V",
"        <sup>",
"         [2]",
"        </sup>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Doxorubicin",
"       </td>",
"       <td>",
"        25 mg/m",
"        <sup>",
"         2",
"        </sup>",
"        IV on days 1 and 15",
"       </td>",
"       <td rowspan=\"7\">",
"        <p>",
"         Repeat cycle every 28 days for a total of 3 cycles",
"        </p>",
"        <p>",
"         Radiotherapy to initial sites 5 cm or larger (dose: 36 Gy)",
"        </p>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Vinblastine&bull;",
"       </td>",
"       <td>",
"        6 mg/m",
"        <sup>",
"         2",
"        </sup>",
"        IV on days 1 and 15",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Mechlorethamine",
"       </td>",
"       <td>",
"        6 mg/m",
"        <sup>",
"         2",
"        </sup>",
"        IV on day 1",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Vincristine&bull;",
"       </td>",
"       <td>",
"        1.4 mg/m",
"        <sup>",
"         2",
"        </sup>",
"        (maximum 2 mg) IV on days 8 and 22",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Bleomycin",
"       </td>",
"       <td>",
"        5 units*/m",
"        <sup>",
"         2",
"        </sup>",
"        IV on days 8 and 22",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Etoposide",
"       </td>",
"       <td>",
"        60 mg/m",
"        <sup>",
"         2",
"        </sup>",
"        IV on days 15 and 16",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Prednisone",
"       </td>",
"       <td>",
"        40 mg/m",
"        <sup>",
"         2",
"        </sup>",
"        oral every OTHER day x 9 weeks then taper",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"3\">",
"        Escalated BEACOPP",
"        <sup>",
"         [3]",
"        </sup>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Bleomycin",
"       </td>",
"       <td>",
"        10 units*/m",
"        <sup>",
"         2",
"        </sup>",
"        IV on day 8",
"       </td>",
"       <td rowspan=\"8\">",
"        Repeat cycle every 21 days",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Etoposide",
"       </td>",
"       <td>",
"        200 mg/m",
"        <sup>",
"         2",
"        </sup>",
"        IV on days 1 through 3",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Doxorubicin",
"       </td>",
"       <td>",
"        35 mg/m",
"        <sup>",
"         2",
"        </sup>",
"        IV on day 1",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Cyclophosphamide&Delta;",
"       </td>",
"       <td>",
"        1250 mg/m",
"        <sup>",
"         2",
"        </sup>",
"        IV on day 1",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Vincristine",
"       </td>",
"       <td>",
"        1.4 mg/m",
"        <sup>",
"         2",
"        </sup>",
"        (maximum 2 mg) IV on day 8",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Procarbazine",
"       </td>",
"       <td>",
"        100 mg/m",
"        <sup>",
"         2",
"        </sup>",
"        oral on days 1 through 7",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Prednisone",
"       </td>",
"       <td>",
"        40 mg/m",
"        <sup>",
"         2",
"        </sup>",
"        oral on days 1 through 14",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        G-CSF",
"       </td>",
"       <td>",
"        SQ starting on day 8",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"3\">",
"        Standard dose BEACOPP",
"        <sup>",
"         [3]",
"        </sup>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Bleomycin",
"       </td>",
"       <td>",
"        10 units*/m",
"        <sup>",
"         2",
"        </sup>",
"        IV on day 8",
"       </td>",
"       <td rowspan=\"7\">",
"        Repeat cycle every 21 days",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Etoposide",
"       </td>",
"       <td>",
"        100 mg/m",
"        <sup>",
"         2",
"        </sup>",
"        IV on days 1 through 3",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Doxorubicin",
"       </td>",
"       <td>",
"        25 mg/m",
"        <sup>",
"         2",
"        </sup>",
"        IV on day 1",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Cyclophosphamide&Delta;",
"       </td>",
"       <td>",
"        650 mg/m",
"        <sup>",
"         2",
"        </sup>",
"        IV on day 1",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Vincristine",
"       </td>",
"       <td>",
"        1.4 mg/m",
"        <sup>",
"         2",
"        </sup>",
"        (maximum 2 mg) IV on day 8",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Procarbazine",
"       </td>",
"       <td>",
"        100 mg/m",
"        <sup>",
"         2",
"        </sup>",
"        oral on days 1 through 7",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Prednisone",
"       </td>",
"       <td>",
"        40 mg/m",
"        <sup>",
"         2",
"        </sup>",
"        oral on days 1 through 14",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"3\">",
"        MOPP",
"        <sup>",
"         [4]",
"        </sup>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Mechlorethamine",
"       </td>",
"       <td>",
"        6 mg/m",
"        <sup>",
"         2",
"        </sup>",
"        IV on days 1 and 8",
"       </td>",
"       <td rowspan=\"4\">",
"        Repeat cycle every 28 days",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Vincristine",
"       </td>",
"       <td>",
"        1.4 mg/m",
"        <sup>",
"         2",
"        </sup>",
"        (maximum 2 mg) IV on days 1 and 8",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Procarbazine",
"       </td>",
"       <td>",
"        100 mg/m",
"        <sup>",
"         2",
"        </sup>",
"        oral on days 1 through 14",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Prednisone",
"       </td>",
"       <td>",
"        40 mg/m",
"        <sup>",
"         2",
"        </sup>",
"        oral on days 1 through 14",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     IV: intravenous; SQ: subcutaneous; G-CSF: granulocyte colony-stimulating factor.",
"     <br>",
"      * 1 unit = 1 mg bleomycin.",
"      <br>",
"       <span class=\"bullet\">",
"        &bull;",
"       </span>",
"       Vinblastine dose reduced to 4 mg/m",
"       <sup>",
"        2",
"       </sup>",
"       and vincristine dose to 1 mg/m",
"       <sup>",
"        2",
"       </sup>",
"       (maximum 2 mg) during cycle 3 for patients 50 years of age or older.",
"       <br>",
"        &Delta; Mesna, total dose is the same as that of cyclophosphamide, administered: 20 percent IV at hour 0; 40 percent orally at hour 2; 40 percent orally at hour 5.",
"       </br>",
"      </br>",
"     </br>",
"    </div>",
"    <div class=\"reference\">",
"     References:",
"     <br>",
"      <ol>",
"       <li>",
"        Canellos GP et al. N Engl J Med1992; 327:1478.",
"       </li>",
"       <li>",
"        Bartlett NL et al. J Clin Oncol 1995; 13:1080.",
"       </li>",
"       <li>",
"        Dann EG et al. Blood 2007; 109:905.",
"       </li>",
"       <li>",
"        DeVita VT et al. Ann Intern Med 1980; 92:587.",
"       </li>",
"      </ol>",
"     </br>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f7_60_8142=[""].join("\n");
var outline_f7_60_8142=null;
var title_f7_60_8143="RF electrodes";
var content_f7_60_8143=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ONC%2F54069&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ONC%2F54069&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    RF electrodes",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 396px; height: 390px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    A) RITA Talon infusion. B) Valley Lab Cool-tip Cluster. C) Boston Scientific 4 cm Levine.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Dupuy, DE, Schirmang, TC.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f7_60_8143=[""].join("\n");
var outline_f7_60_8143=null;
